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POLYCAPROLACTONE NANOWIRE SURFACES AS INTERFACES FOR 
CARDIOVASCULAR APPLICATIONS 
 
Cardiovascular disease is the leading killer of people worldwide. Current treatments 
include organ transplants, surgery, metabolic products and mechanical/synthetic implants. Of 
these, mechanical and synthetic implants are the most promising. However, rejection of 
cardiovascular implants continues to be a problem, eliciting a need for understanding the 
mechanisms behind tissue-material interaction. Recently, bioartificial implants, consisting of 
synthetic tissue engineering scaffolds and cells, have shown great promise for cardiovascular 
repair. An ideal cardiovascular implant surface must be capable of adhering cells and providing 
appropriate physiological responses while the native tissue integrates with the scaffold.  
However, the success of these implants is not only dependent on tissue integration but also 
hemocompatibility (interaction of material with blood components), a property that depends on 
the surface of the material. A thorough understanding of the interaction of cardiovascular cells 
and whole blood and its components with the material surface is essential in order to have a 
successful application which promotes healing as well as native tissue integration and 
regeneration. The purpose of this research is to study polymeric nanowire surfaces as potential 
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Cardiovascular disease affects 80 million people in the US and is the leading cause of 
death worldwide. Current treatments for cardiovascular diseases include organ transplants, 
surgery, metabolic products and mechanical/synthetic implants. Of these, mechanical and 
synthetic implants have shown great promise in recent years, however, synthetic polymers have 
been recognized as better candidates for cardiovascular repair due to the thrombogenic nature of 
metallic cardiovascular implants. In particular, polymers such as polyurethane, poly(L-lactic 
acid), polyglycolic acid  and polycaprolactone  have proven to be of tremendous use due to their 
biocompatibility and controlled mechanical properties. These polymers have been used to 
develop cardiovascular devices such as vascular grafts, artificial hearts, and heart valves, all of 
which have been widely used in recent years. These implants have the potential to replace the 
damaged components of the cardiovascular system, while maintaining the normal tissue 
function, however, a thorough understanding of the interaction between cells and the biomaterial 
interface involved is essential in order to have a successful application which promotes healing 
as well as native tissue integration and regeneration.  
An ideal scaffold utilized for cardiovascular engineering should be both physically and 
chemically biomimetic. A cardiovascular scaffold must be capable of adhering cells, providing a 
physiochemical biomimetic environment throughout the degradation process and promoting 
desirable physiological responses while the native tissue integrates with the scaffold. However, 
the success of these implants is not only dependent on tissue integration but also 
hemocompatibility (interaction of material with blood components), a property that depends on 
the surface of the material. Therefore, in order to create a successful scaffold and induce 
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transplant tolerance, it is critical to understand the interaction of cells and blood components 
with the material surface. 
This Ph.D. document addresses the hypothesis that polymeric nanowire surfaces will 
provide an advantageous interface for cardiovascular cell functionality and hemocompatibility; 
leading to enhanced cardiovascular biomaterial implant tolerance. The results of this work 
identify enhanced endothelial cell and smooth muscle cell interaction and improved 
hemocompatibility of polycaprolactone nanowire surfaces. This research presents promising 
results with respect to the use of polycaprolactone nanowire surfaces as interfaces for the 
cardiovascular applications.  
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HYPOTHESIS AND SPECIFIC AIMS 
 
Fundamental Hypothesis 
Polymeric nanowire surfaces will provide an advantageous interface for cardiovascular cell 




Hypothesis (1): Nanowire polymeric surfaces can be engineered from polycaprolactone to be 
highly reproducible as interfaces for cardiovascular implantable devices using a nanotemplating 
technique. 
Specific Aim 1: Fabricate and characterize highly reproducible polycaprolactone nanowire 
surfaces for cardiovascular applications. This research is discussed in Chapter 2. 
(a) Fabricate well-controlled, highly reproducible polymeric nanowires using a solvent free 
nanotemplating technique. Fabricate well-controlled, highly reproducible polymeric 
nanofibers using the electrospinning technique. 
(b) Characterize the surface of polycaprolactone nanowires and nanofibers surfaces using 
contact angle and SEM. 
(c) Immobilize type 1 collagen unto the surface of polycaprolactone nanowires. 
(d) Characterize the surface characteristics of collagen immobilized polycaprolactone 
nanowire surfaces using contact angle SEM, and XPS. 
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Hypothesis (2): The orientation of nanostructured polymeric surfaces can modulate protein 
adsorption, platelet adhesion and activation and whole blood clotting on cardiovascular implant 
interfaces. 
Specific Aim 2: Determine the effect of nanostructured polymeric surfaces on the behavior of 
protein adsorption, platelet adhesion and activation and whole blood clotting. This research is 
discussed in Chapter 3.  
(a) Investigate the effect of nanostructured polymeric surfaces on the adsorption of key blood 
proteins (fibrinogen, albumin and immunoglobulin-G). 
(b) Investigate the effect of nanostructured polymeric surfaces on platelet adhesion and 
activation. 
(c) Investigate the effect of nanostructured polymeric surfaces on the blood clotting kinetics 
by measuring the free hemoglobin concentration. 
 
 
Hypothesis (3): Polycaprolactone nanowire surfaces will provide a favorable interface for the 
growth and maintenance of endothelial cell functionality. 
Specific Aim 3: Determine endothelial cell functionality on polycaprolactone nanowire surfaces. 
This research is discussed in Chapter 4.  
(a) Investigate the effect of polycaprolactone nanowire surfaces on the functionality 
(adhesion, proliferation, viability, and morphology) of endothelial cells. 
(b) Investigate the effect of polycaprolactone nanowire surfaces on the endogenous protein 
expression of human microvascular endothelial cells. 
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Hypothesis (4): Polycaprolactone nanowire surfaces will provide a favorable interface for the 
growth and maintenance of smooth muscle cell functionality. 
Specific Aim 4: Determine smooth muscle cell functionality on polycaprolactone nanowire 
surfaces on. This research is discussed in Chapter 5.  
(a) Investigate the effect of polycaprolactone nanowire surfaces on the functionality (adhesion, 
proliferation, viability, and morphology) of smooth muscle cells. 
(b) Investigate the effect of polycaprolactone nanowire surfaces on the endogenous protein 
expression of human aortic smooth muscle cells. 
 
Hypothesis (5): Polycaprolactone nanowire surfaces will provide a favorable cardiovascular 
implant interface for blood and its components. 
Specific Aim 5: Determine the effect of polycaprolactone nanowire surfaces on whole blood and 
its components by investigation of cytotoxicity, platelet/leukocyte interactions, activation of 
complement and contact, thrombin generation and hemolysis. This research is discussed in 
Chapter 6.  
(a) Investigate toxicity of polycaprolactone nanowire surfaces through the use of whole 
blood plasma. 
(b) Investigate fibrinogen binding on polycaprolactone nanowire surfaces through the use of 
whole blood plasma. 
(c) Investigate the effect of polycaprolactone nanowire surfaces on platelet/leukocyte 
adhesion, aggregation and complex formation on polycaprolactone surfaces through the 
use of whole blood plasma.  
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(d) Investigate the activation of complement and contact on polycaprolactone nanowire 
surfaces through the use of whole blood plasma. 
(e) Investigate thrombin generation and hemolysis on polycaprolactone nanowire surfaces.  
 
Hypothesis (6): Polycaprolactone nanowire surfaces will provide a favorable interface for the 
growth and maintenance of co-cultures of endothelial cells and smooth muscle cells and increase 
cellular functionality. 
Specific Aim 6: Determine the functionality of co-cultures of endothelial cells and smooth 
muscle cells on polycaprolactone nanowire surfaces. This preliminary research is discussed in 
Chapter 7. 
(a) Investigate the effect of polycaprolactone nanowire surfaces on the adhesion and 
morphology of co-cultures of human microvascular endothelial cells and human aortic 
smooth muscle cells. 
(b) Investigate the effect of polycaprolactone nanowire surfaces on the endogenous protein 








Cardiovascular disease affects 80 million people in the US and is the leading cause of death 
worldwide. Current treatments for cardiovascular disease include organ transplants, surgery, 
metabolic products and mechanical/synthetic implants [1]. Of these, mechanical and synthetic 
implants have shown great promise in recent years, however, synthetic polymers have been 
recognized as better candidates for cardiovascular repair due to the thrombogenic nature of 
metallic cardiovascular implants [2]. In particular, polymers such as polyurethane [3], poly(L-
lactic acid) [4], polyglycolic acid [5] and polycaprolactone [6] have proven to be of tremendous 
use due to their biocompatibility and controlled mechanical properties. The thermal and tensile 
properties of degradable polymers used in medical applications have been previously 
characterized [7], and a summary of these properties are listed in Table 1.1. [8]. These polymers 
have been used to develop cardiovascular devices such as vascular grafts [9], artificial hearts 
[10], and heart valves [11], all of which have been widely used in recent years [12]. Implants 
have the potential to replace the damaged components of the cardiovascular system, while 
maintaining normal tissue function. However, these implants have significant limitations even 
after decades of research devoted to developing blood-contacting devices [13, 14]. The greatest 
shortcoming is the lack of complete biocompatibility, leading to poor tissue/biomaterial 
integration and further biomaterial rejection [15]. Hence, an unmet need exists to develop novel 
cardiovascular implant surfaces capable of promoting healing as well as native tissue integration 
and regeneration.  
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A well-documented, complex cascade of highly interconnected events are initiated in 
response to blood and tissue interacting with the surface of a biomaterial [16, 17]. The successful 
integration of long-term implantable devices is highly dependent on the initial events of 
tissue/biomaterial interaction, promoting wound healing response (extracellular matrix 
production and vascularization) or rejection of the biomaterial surface with creation of a fibrous 
capsule (Figure 1.1.). The cells needed for the regeneration of healthy tissue are hindered 
through an unfavorable immune reaction, thus compromising the wound healing process and  
Table 1.1. Properties of Polymers. Reproduced with permission from Elsevier © [8]. 
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the wound healing process and long term success of implantable biomedical devices [18, 19]. 
There are an assortment of biochemical and topographical cues present naturally within human 
tissues that have favorable interactions with whole blood components and cells of the 
cardiovascular system [20, 21]. By mimicking these cues on scaffold surfaces promising cellular 
responses have been elicited via biomolecular recognition [22-25], which can easily be regulated 
with changes to the design parameters of the material surface [26]. An in depth understanding of 
the reactions that both nanoscaled topographical cues and biochemical cues elicit in cellular 
functionality is critical in determining the long term success of a cardiovascular implant device.  
 
Figure 1.1. Two fates of a cardiovascular implant, either leading to tissue/biomaterial integration 




















1.2. Physiological Response to Implanted Biomaterials  
When blood comes in contact with a material surface, an intricate series of highly 
interconnected events such as platelet and leukocyte adhesion/activation and stimulation of 
complement and coagulation cascades are initiated, ultimately controlled by properties of the 
surface (Figure 1.2) [27]. Key blood serum proteins, such as fibrinogen, immunoglobulin G and 
albumin can adsorb and undergo conformational changes on the surface, thus intermediating 
these events. Proteins can adsorb on the surface in varying quantities, densities, conformations, 
and orientations, depending on the chemical and physical characteristics of the surface [28]. The 
layer of adsorbed proteins influences the adhesion and activation of platelets and leukocytes. 
Platelets are anuclear specialized blood cells released from megakaracytes in bone marrow. The 
central role of platelets is to terminate haemorrhage following tissue trauma, initiated through the 
activation of platelets and resulting in the release of a multitude of bioactive factors, such as PF-
4 and P-selectin, from platelet granules [29-31]. Platelets are further activated when red blood 
cells are lysed in response to contacting an unfavorable surface, releasing adenosine diphosphate 
(ADP), promoting platelet aggregation on the material surface [32]. In turn leukocytes are 
recruited and infiltrate unto the surface, facilitating the formation of platelet/leukocyte 
complexes (heterotypic aggregates) [33]. Leukocytes are involved in defending the body against 
disease and foreign materials and are produced by hematopoietic stem cells. There are five 
different types of leukocytes (neutrophils, basophils, eosinophils, lymphocytes, monocytes), each 
serving a specific function. Heterotypic aggregates form when activated platelets undergo 
degranulation, after which they adhere to circulating leukocytes via P-selectin [34]. This further 
stimulates two pathways, better known as the intrinsic pathway (contact activation) and the 
extrinsic pathway (tissue factor), which may lead to thrombosis and/or a fibrous capsule. Both 
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pathways involve zymogens activating, eventually converging on a common pathway, leading to 
clot development via formation of thrombin from prothrombin and fibrin from fibrinogen [35]. 
Thus, in order to fully evaluate the physiological response to the surface of a biomaterial, all of 
these events must be investigated and understood.  
Figure 1.2. Representative schematic of blood response to an implanted biomaterial. 
1.3.Structure of cardiovascular tissue. 
Cardiovascular tissue, whether looking at arteries or veins, is composed of three main layers 
of cells (endothelial cells, smooth muscle cells, fibroblasts) (Figure 1.3.). The tunica intima is 



























Figure 1.3. Composition of cardiovascular tissue. Reproduced with permission from Springer © 
[36]. 
composed of endothelial cells. This layer is in constant exposure to blood and is similar in both 
arteries and veins. The tunica media is composed of smooth muscle cells and this layer varies in 
arteries and veins. An increase in smooth muscle is present in arteries to provide extra strength 
and elasticity in response to surges of blood from the heart. The tunica externa/adventitia is 
connective tissue composed of fibroblasts. Further collagen is the most abundant protein in the 
ECM of cardiovascular tissue. 
1.4.Endothelial cell-material interface.  
The endothelium is a selectively permeable barrier, separating blood from the underlying 
cellular layers (Figure 1.3.). Damage of the endothelial cell (EC) layer exposes the underlying 
subendothelial extracellular matrix, promoting thrombus formation, inflammation and smooth 
muscle cell proliferation, thus demonstrating the importance of re-establishing or maintaining the 
integrity of the EC layer. Previous research has shown that stents seeded with ECs before being 
implanted can inhibit thrombosis and neointimal hyperplasia [37, 38], however ECs are not able 
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to maintain adherence when exposed to physiological blood flow. Ensuring their robust 
adherence capable of withstanding the physiological forces caused by blood flow is vital. Any 
interruption of contact between terminally differentiated ECs and blood flow is expected to 
produce an undesirable response that would interfere with proper tissue integration. Non-
adherent surfaces prevent ECs from attaching to the endovascular surface, which in turn impedes 
the development of a protective endothelium. An unmet need therefore exists, to engineer 
cardiovascular implant surfaces that encourage the development of endothelium. 
One major obstacle to overcome is adhering the anchorage-dependent ECs. The level of 
growth is correlated to the characteristics of the surface and how well the surface mimics 
cardiovascular ECM. Consequently, in order to create a successful cardiovascular scaffold 
surface, it is necessary to mimic the interaction between the ECs surface receptors with the 
extracellular matrix molecules. This interaction is extremely important in regulating adhesion, 
survival, proliferation, migration and differentiation. Once ECs establish adhesive contacts with 
surfaces via integrin-mediated interactions, signaling pathways are activated that initiate and 
direct a diverse amount of cellular activities such as survival, cell-cycle progression, 
vascularization for oxygenation and nutrient delivery and gene expression [39]. Therefore, the 
functionality of ECs is dependent on the success of their adherence to the surface. Understanding 
how to anchor ECs and the nature of the cell surface receptor-ECM interactions will provide a 
foundation for developing functional biomaterials designed to promote EC adhesion and 
growth.  Further, maintaining normal physiological functions of endothelial cells in vitro is a 
requirement for the successful endothelialization of biomaterials. Therefore studies have been 
focused on improving endothelial cell attachment and functionality on a variety of polymer 
surfaces, via surface coatings or the introduction of nanotopography. For example, collagen-
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coated poly(L-lactic acid)-co-poly(epsilon-caprolactone) nanofibers have shown increased 
spreading, viability, attachment and differentiation of ECs [40] and the surface topography of 
nano/micro-fiber scaffolds fabricated from a blend of starch and polycaprolactone have been 
shown to elicit and guide the 3D distribution of ECs [23]. 
 
1.5. Endothelial-smooth muscle cell interaction. 
The communication between cells is essential for the normal maintenance of tissue and a 
number of pathophysiological responses [41]. In particular, cardiovascular tissue requires 
interactions between the endothelium with the underlying smooth muscle cells (SMCs), which is 
vital for cardiovascular health and is considered to be important in the functions of blood vessels 
[42, 43]. Maintenance of arterial structure relies on this interaction. ECs and SMCs act as a 
linked system for the communication of signals from receptors confined on the endothelium 
surface to the arterial wall and vice versa. It has been shown that bidirectional electrical signals 
flow in response to kinins between ECs and SMCs [44]. ECs and SMCs in the vascular wall can 
also communicate through the release of signals into the surrounding medium, or via direct cell-
cell contact through junctions formed between the cells [45]. For example, during 
vasculogenesis, growth factors released from ECs promote migration of undifferentiated 
mesenchymal cells towards ECs and upon contact with ECs the mesenchymal cells differentiate 
into SMCs [46].  
Further, ECs produce both growth inhibitors and stimulators of SMCs. In order to prevent 
thrombosis, restenosis and ultimate failure of the implant, an intact endothelium at the vessel-
biomaterial interface is fundamental, in turn also preventing over-proliferation of the smooth 
muscle cells. In particular nitric oxide (NO), released by ECs, is responsible for inhibiting the 
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proliferation of SMCs via the extracellular signal-regulated kinase (ERK) pathway [47]. Studies 
have also shown that the rate of proliferation of SMCs is directly dependent on the state of 
endothelium [48]. When the endothelium is proliferating, the rate of proliferation of SMCs is 
accelerated. However, when the endothelium is in a confluent state, the normal growth rate of 
SMCs is completely inhibited. For examples, ECs cultured with synthetic state SMCs separated 
by a porous membrane demonstrated increased EC adhesion molecule expression, suggesting 
that synthetic SMCs activate the endothelium [49]. Therefore a specific ratio of ECs to SMCs 
and maintenance of a differentiated cellular state is vital to healthy cardiovascular tissues. 
 
1.6. Smooth muscle cell-surface interaction. 
The vascular SMCs main function is contraction and adjustment of blood vessel 
diameter, blood pressure, and blood flow distribution [50]. SMCs have the capacity for 
contraction, migration, proliferation, synthesis of extracellular matrix (ECM) components and 
the secretion of growth factors and cytokines [51]. This allows SMCs to regulate lumen diameter 
both transiently and chronically [52]. SMCs are key players in the development of vascular 
disease due to their plasticity or ability to change phenotype and behavior according to varying 
environmental conditions [53]. SMCs exhibit two well-known phenotypes; contractile and 
synthetic [54]. Contractile SMCs are elongated and spindle shaped, whereas synthetic SMCs are 
less elongated and have an epithelioid morphology. Synthetic SMCs contain organelles involved 
in protein synthesis, whereas in contractile SMCs, these organelles are replaced with contractile 
filaments. Further, synthetic and contractile SMCs exhibit different proliferation rates. Synthetic 
SMCs proliferate at higher rates compared to contractile SMCs. Contractile SMCs in adult blood 
vessels proliferate at an exceptionally low rate, demonstrate low synthetic activity, and express a 
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high level expression of contractile myofilament proteins such as α-smooth muscle actin (α-
SMA), calponin, and myosin [55, 56]. The increased growth potential of smooth muscle cells 
causes them to be the most significant in vascular diseases such as atherogenesis and intimal 
hyperplasia. Recent studies show that smooth muscle cells express calcium channels, ICAM-1 
and VCAM-1 suggesting that they may contribute to inflammatory reaction as well as the 
progression of vascular disease [57]. 
SMCs continue to react unfavorably when in contact with biomaterials, switching to a 
synthetic phenotype. Recently, research has been aimed at developing material surfaces that 
induce the contractile state of SMCs, thus reducing proliferation, preventing complications such 
as restenosis.  SMCs cultured on nanopatterned poly(methyl methacrylate) (PMMA) 
andpoly(dimethylsiloxane) (PDMS) surfaces have exhibited a more elongated phenotype and a 
reduction in proliferation [58]. Further, a decrease in VSMC proliferation and increased 
expression of smooth muscle α-actin was seen on nanotubular titanium oxide [59]. These results 
suggest a correlation between nanotopography and smooth muscle cell proliferation and 
differentiation. 
 
1.7. Nanostructured surfaces for cardiovascular tissue engineering applications. 
Cells are naturally sensitive to their environment. The extracellular matrix (ECM) of all tissues 
is a multifaceted cellular environment consisting of proteins, proteoglycans, and other soluble 
molecules that are constantly interacting with surrounding cells (Figure 1.4.). These elements 
that constitute the ECM of macroscale human tissues are on the micrometer and nanometer scale 
[20]. The ECM offers mechanical support, biochemical cues and biomechanical cues that are 
important for cell functionality. However, the structure of the ECM varies within each tissue and 
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exhibits a variety of forms at different stages of development [60]. Developing and tailoring a 
favorable environment that mimics the complex, nanoscaled organization of native ECM is the 
most crucial aspect of tissue engineering and one, which remains to be the most difficult.  
The motivation to use nanostructured surfaces as interfaces for cardiovascular devices is 
driven by previous studies that have shown that nanoscale materials affect cell behavior such as 
morphology, functionality and cell-cell interactions [61-63]. Nanotopography provides a 
valuable technique for guiding cell growth and differentiation, providing more durable features 
than surface chemistry alone and is capable of being modified in size and shape to match the 
chosen application. It is of utmost importance to mimic the in vivo environment of cells when 
designing scaffolds for tissue engineering. Furthermore, studies have shown that nanoscale 
surfaces improve fibroblast cell adhesion [64], neuronal cell differentiation [39], and osteoblast 
phenotypic activity [65, 66]. Therefore, nanotopography may result in improved cellular 
adhesion and therefore, enhanced matrix deposition and an increase in cardiovascular cell 
differentiation markers.  
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Figure 1.4. Cellular interaction with components of the extracellular matrix. Reproduced with 
permission from Springer © [67]. 
1.8. Current polymers used for cardiovascular applications. 
Current materials used for cardiovascular stents are either bare metal, such as stainless 
steel, tantalum and cobalt chromium alloys, or coated metal stents. Pure polymer stents are 
currently not FDA approved, however polymers are commonly used for coating stents. Polymers 
used for coating stents can be organized as biostable polymers, biodegradable polymers, 
copolymers, and biological polymers [68]. A polymer coating allows for drug elution, which has 
been shown to prevent thrombosis [69].  Three drugs; heparin, sirolimus, and paclitaxel, have 
been investigated vigorously for treating and/or preventing restenosis. Current drug eluting stent
products include CYPHER(®)  a sirolimus-eluting Coronary Stent, Taxus(®), Liberte(®), 
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XIENCE V(™) / Promus(®) and Endeavor Resolute(®) [70]. The CYPHER® stent is composed 
of three polymer layers. A parylene layer is directly applied to the stent surface, followed by a 
polyethylene-co-vinyl acetate and poly-n-butyl methacrylate mixture containing the sirolimus 
drug. A top layer of only polyethylene-co-vinyl acetate and poly-n-butyl methacrylate is applied 
in order to control the elution rate or sirolimus. The Taxus® device has a single copolymer, 
poly(styrene-b-isobutylene-b-styrene), mixed with the paclitaxel drug. Further 
phosphorylcholine coatings are used for the delivery of the Zotarolimus drug from the 
Endeavor® stent. However, phosphorylcholine-based coatings have also been used as coatings 
without drug delivery capabilities [71]. Materials commonly used for vascular grafts include 
artificial grafts, autologous tissue, allografts and xenografts. Common artificial vascular graft 
materials include expanded poly-tetrafluoroethylene (ePTFE; Gore-Tex), poly-
tetrafluoroethylene (Teflon; E.I. du Pont de Nemours and Company) or polyethylene 
terephthalate (Dacron). 
 
1.9. Current FDA approved polycaprolactone devices. 
Polycaprolactone (PCL) is used in a number of FDA approved devices such as sutures, 
barrier adhesion, wound dressings, contraceptive devices, tissue scaffolds, fixation devices, and 
in dentistry. Neurolac® is an FDA approved nerve guide conduit device and is a co-polymer of 
poly(dl-lactide-ɛ-caprolactone) and PCL [72]. PolyRemedy’s PolyFIT™ antimicrobial dressings, 
composed of polyethylene glycol, ethylene vinyl alcohol and PCL, were recently FDA approved 
for wound care [73]. The OsteoPlugTM is also composed of a bioresorbable PCL scaffold for 
burr-hole skull defects. A block copolymer of PCL with glycolide is being sold as a 
monofilament suture under the trade name MONOCRYL® by Ethicon. In dentistry, a PCL 
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composite known as Resilon is used as a component of night guards and also in root canal 
fillings. PCL is also FDA approved in Capronor®, a commercial contraceptive product that is 
able to deliver levonorgestrel in vivo for over a year [74]. 
 
1.10. Polycaprolactone for cardiovascular tissue engineering applications. 
Although PCL is not currently FDA approved for use in cardiovascular tissue engineering 
applications, it has a vast amount of benefits.  The solubility of PCL in various solvents, its low 
melting point (~60 °C), and its rare miscibility with a vast amount of other polymers has 
stimulated extensive research into its potential application in the biomedical field [75-77]. PCL 
has emerged as a promising implant polymer due to the fact that it is a bioresorbable polyester 
with exceptional mechanical strength as well as a tunable degradation rate and glass transition 
temperature of about 60 °C. PCL biodegrades within several months to several years depending 
on factors such as the molecular weight, the degree of crystallinity of the polymer, and the 
conditions of degradation [78-81]. It is derived by chemical synthesis from crude oil and can be 
prepared by ring opening polymerization of ε-caprolactone using a catalyst. It has good water, 
oil, solvent and chlorine resistance but can be degraded by hydrolysis of its ester linkages in 
physiological conditions (such as in the human body) and its degradation products are easily 
bioresorbed or removed naturally in metabolic pathways such as the citric acid cycle. 
Degradation of PCL was studied in vivo in rats [82]. Results reveal that PCL with a molecular 
weight of 66000 remained intact after 2 yrs of implantation while its molecular weight dropped 
to 15000. PCL with a molecular weight of 3000 was radioactively tagged and results reveal that 
the material did not accumulate in the body tissue and could be completely excreted. 
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Extensive in vitro and in vivo biocompatibility and efficacy studies have been performed 
with PCL, resulting in US Food and Drug Administration approval of a number of medical 
devices. Recently, PCL has been investigated for tissue engineering and drug delivery 
applications. It is regarded as a soft and hard tissue compatible bioresorbable material and has 
been considered as a potential substrate for wide applications, such as drug delivery systems, 
tissue-engineered skin, axonal regeneration [83] and scaffolds for supporting fibroblasts and 
osteoblasts growth. PCL is a versatile polymer, capable of being transformed into a variety of 
topographies and structures. These include nanospheres [84, 85] nanowires [86, 87], nanofibers 
[88, 89], biodegradable thermoresponsive physical hydrogel nanofibers [90] and ultra-thin 
membranes [91] (Figure 1.5). 
 
Figure 1.5. Nanostructured topographies from PCL: Nanospheres (a,b). Nanofibres (c,d). Foams 
(e,f). Knitted textiles (g,h,i). Selective laser sintered scaffold (j-o). Fused deposition modeled 
scaffolds (p–u). Reproduced with permission from Elsevier © [8]. 
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1.11. Type 1 Collagen. 
Collagen, the main protein in the ECM of blood vessels as well as other tissues in the body, 
has been used extensively to promote cell adhesion [92], specifically for fibroblasts [93], human 
keratinocytes [94], epithelial cells [95], and endothelial cells [96, 97]. Cell adhesion to collagen 
is controlled by two integrins: α1β1 and α2β1 [98]. Fibrillar collagen (collagen type I) binds 
these cellular integrins while exhibiting a triple helical structure, essential to its biological and 
mechanical properties [99]. Integrin α1β1 binds to collagen via MIDAS motif and is the only 
collagen receptor capable of activating Shc mediated growth pathways, indicating a distinctive 
role in cell proliferation on collagen [100]. Integrin α2β1 preferentially binds to a triple helical 
collagen containing the GFOGER motif [101] and regulates the level of matrix 
metalloproteinase-1[102]. Thus, collagen has been incorporated onto biomaterial surfaces to 
promote adhesion via integrin-mediated pathways. For example, collagen has been incorporated 
into nanofiber matrices and has enhanced rat tibia tissue regenerative processes [103], increased 
human fibroblast activity [104] enhanced proliferation and differentiation of neural precursor 
cells [105], improved bioactivity for bone engineering [106, 107] and increased endothelial cell 
organization and cell survival [108] and increased viability of both smooth muscle cells and 
endothelial cells [109]. Collagen has also been immobilized [110-112] or conjugated onto a 
variety of surfaces [40, 113, 114] enabling it to be used in a vast amount of applications. 






1.12. Experimental Approach. 
Studies have demonstrated that biomimetic surfaces elicit favorable cellular interactions [22-
24], which can be controlled by altering surface properties [21, 25, 117, 118]. Recent 
technologies have facilitated the fabrication of nanostructures on biomaterial surfaces, such as 
nanofibers [119, 120], nanowires [121, 122], nanorods [123], nanoparticles [122] and nanotubes 
[124, 125]. Topographies at the nanoscale level have stimulated various changes in cell adhesion 
[126], motility [127], alignment [128], and gene expression [129, 130].  In particular nanoscale 
architectures have improved proliferation of endothelial cells and smooth muscle cells [131], 
augmented differentiation of mesenchymal stem cells into the osteoblast phenotype [132, 133], 
and controlled growth patterns of neurons [134]. Promoting the functionality of cells further 
stimulates tissue-biomaterial integration, which can inhibit the rejection of the biomaterial [135, 
136]. All of these studies suggest that there is a correlation between nanoscale surface features 
and cellular functionality. 
In this work, we present a novel solvent-free template synthesis technique for fabricating 
controlled arrays of high aspect ratio, substrate-bound nanowires from PCL, a biocompatible and 
biodegradable polymer. Template synthesis is a simple procedure, which provides a controlled 
approach for developing nanoscale polymer constructs for tissue engineering applications in 
solvent free conditions, which eliminates issues of toxicity. Previous research has shown that 
PCL nanowires enhance the growth of neurons and promote mesenchymal stem cell 
differentiation but nothing is known about how whole blood and its components, endothelial 
cells and smooth muscle cells will interact with this nanotopography [87, 137]. Further, collagen 
type 1 will be immobilized to the PCL nanowire surfaces.  
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The development of nanostructured platforms based on novel PCL nanowire surfaces 
immobilized with collagen will provide key insights into cell-material interactions for the 
development of improved interfaces for cardiovascular implants. It is envisioned that the 
incorporation of mechanical and biochemical signals on scaffolds will further facilitate the 
growth and maintenance of differentiated cell states, and provide long-term cell viability and 
functionality. It is anticipated that these nanowire surfaces will be able to provide a template for 
growth and maintenance of human microvascular endothelial cells and human aortic smooth 
muscle cells. We believe that molecular and cellular assessment of in vitro responses to scaffold 
topography will contribute to the improvement of cardiovascular tissue engineering surfaces. 
These nanostructured surfaces, which are not able to allow cellular in-growth due to their size, 
may instead, provide a biomimetic template for ECM deposition, acting as a framework that 
facilitates synthesis of new cardiovascular tissue. In addition to creating more robust 
nanostructured scaffold material, we hope to better understand the role of both mechanical and 
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FABRICATION OF POLYCAPROLACTONE NANOSTRUCTURED SURFACES 
 
2.1. Introduction 
Current treatments for cardiovascular disease include organ transplants, surgery, 
metabolic products and mechanical/synthetic implants [1]. Of these, mechanical and synthetic 
implants have shown great promise in recent years, however, synthetic polymers have been 
recognized as better candidates for cardiovascular repair due to the thrombogenic nature of 
metallic cardiovascular implants [2]. In particular, polymers such as polyurethane [3], poly(L-
lactic acid) [4], polyglycolic acid [5] and polycaprolactone (PCL) [6], have proven to be of 
tremendous use due to their biocompatibility and controlled mechanical properties. These 
polymers have been used to develop cardiovascular devices such as vascular grafts [7], artificial 
hearts [8], and heart valves [9], all of which have been widely used in recent years [10]. Implants 
have the potential to replace the damaged components of the cardiovascular system, while 
maintaining normal tissue function. However, these implants have significant limitations even 
after decades of research devoted to developing blood-contacting devices [11, 12]. The greatest 
shortcoming is the lack of complete biocompatibility, leading to poor tissue/biomaterial 
integration and further biomaterial rejection [13]. 
PCL has emerged as a promising implant polymer due to the fact that it is a bioresorbable 
polyester with exceptional mechanical strength as well as a tunable degradation rate and glass 
transition temperature of about 60 °C. Extensive in vitro and in vivo biocompatibility and 
efficacy studies have been performed with PCL, resulting in US Food and Drug Administration 
approval of a number of medical devices. PCL is a versatile polymer, capable of being 
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transformed into a variety of topographies and structures. These include nanospheres [14, 15] 
nanowires [16, 17], nanofibers [18, 19], biodegradable thermoresponsive physical hydrogel 
nanofibers [20] and ultra-thin membranes [21]. In this work, we explore responses to two 
different nanotopographies, nanofiber and nanowire. PCL nanofibers were fabricated with an 
electrospinning technique and a novel solvent-free template synthesis technique was used to 
fabricating controlled arrays of high aspect ratio, substrate-bound nanowires. These two 
nanotopographies were chosen because they have similar sized features that are aligned 
differently; NWs are aligned perpendicular to the surface while NFs are aligned parallel to the 
surface. It is hypothesized that this alteration in the alignment of nanostructures on the surface 
will result in a very different response to blood components, thus altering the hemocompatibility. 
 
2.2. Materials and Methods 
2.2.1. PCL nanofiber fabrication 
 PCL nanofiber (notation: NF) surfaces were fabricated by an electrospinning technique 
(Figure 3.1.). The electrospinning apparatus consisted of a syringe pump, a glass syringe, teflon 
fluidic tubing, a 20-gauge blunt-tip catheter, and a male luer lock adapter. A high-voltage power 
source was connected to the catheter tip with a standard alligator clamp. The collector consisted 
of an aluminum foil fastened onto a 0.5” thick copper plate with electrical tape and positioned 
horizontally below the catheter. Polymer solution was prepared by dissolving oleic acid sodium 
salt (OLA) in methanol. PCL pellets (MW = 80000) were dissolved in chloroform and the 
polymer solution was mixed with OLA in methanol on a magnetic stir plate to produce a 
homogeneous mixture with a 4:1 chloroform:methanol volume ratio. The final solution was 12% 
solid w/w and the PCL:OLA ratio of the solid weight was 97:3 [22]. The volumetric flow rate 
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was 10ml/hr, applied voltage was 20 kV, and tip-to-collector was distance 9cm. Finally, OLA 
was leached out by placing nanostructured surfaces in methanol for 1h.  
All the surfaces that were used for biological studies were approximately 1cm in 
diameter.  The surfaces were sterilized in 70% ethanol for 30mins, followed by washing (2!) 
with PBS. They were air dried and further sterilized by uv exposure for 30mins before using for 
biological studies. 
Figure 2.1. Schematic of how PCL nanofiber surfaces were fabricated. 
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2.2.2. Fabrication of PCL nanowire surfaces 
Control (smooth PCL) surfaces were fabricated by sintering PCL pellets (MW = 80000, 
Sigma) on a glass plate in a 10 mm Teflon washer. The resulting discs were then air-cooled 
before using a biopsy punch to ensure a common diameter between all surfaces (10 mm).  
PCL nanowire surfaces were fabricated using a solvent free nanotemplating technique 
with 20 nm diameter nanoporous aluminum oxide membranes [23] (Figure 2.2.). Previously 
fabricated PCL discs were placed on the membrane surface and placed in an oven at 115 °C for 
3-5 min, thus allowing the nanowires to gravimetrically extrude through the membrane. The 
aluminum oxide membranes were then dissolved in 1 M NaOH for 75 min and surfaces were 
then washed in DI water (3x), dried and stored in a desiccator until their use was required.  
Prior to any further use, all surfaces were sterilized in 70 % ethanol for 30 min, followed 
by washing with PBS (2x). Surfaces were then air dried and further sterilized by UV exposure 
for 30 min. 
Figure 2.2. Schematic of how PCL nanowires were made via nanotemplating technique. PCL is 
extruded through an alumina membrane (top left), alumina is dissolved producing nanowire 
surfaces. 
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2.2.3. Immobilization of Collagen on PCL and NW surfaces 
 Surfaces fabricated as described in section 2.3 were immobilized with collagen in three 
steps: 
1. The surfaces were aminolyzed by incubating in 1,6-hexanediamine/2-propanol (6 % w/v) 
for 10 min at 37 ºC followed by rinsing with DI water (3x) to remove free 1,6-
hexanediamine.  
2. The surfaces were then incubated in a gluteraldehyde (1 % w/v) solution at 2-4 °C for 24 
hrs and then rinsed with DI water (3x) to remove free gluteraldehyde. 
3. Surfaces were then incubated in collagen (1 % w/v) for 24 hrs at 2-4 °C. Following the 
incubation, surfaces were rinsed with 0.1 M acetic acid solution, followed by DI water 
(3x) to remove excess, ungrafted collagen. 
 
Note: Notation for different surfaces in the rest of this dissertation is as follows - Control (PCL), 
Control+Collagen (cPCL), Nanowire (NW), Nanowire+Collagen (cNW), Nanofiber (NF).  
 
2.2.4. Characterization of PCL nanowire and nanofiber surfaces 
 The surface architecture of the nanostructured surfaces was characterized using scanning 
electron microscope (SEM, JEOL JSM-6300). The surfaces were coated with a 10 nm layer of 
gold and imaged at 5-7 kV. Nanowire and nanofiber diameters and heights were computed using 
the image analysis system built into the SEM. 
 Surface hydrophilicity was characterized by measuring the contact angle of DI water 
(Figure 2.3.). A droplet of DI water, approximately 100 µL in volume, was formed on the tip of 
the syringe and the machine stage was moved upward so that the droplet contacted and detached 
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onto the surface. The water droplet image on the surface was captured within 5 secs after the 
contact by a camera leveled with the surface. Images were then analyzed with the accompanying 
software to measure the contact angles.  Each experiment was performed on three different 
locations on each surface, and on at least three different surfaces (nmin = 9) [24]. 
Figure 2.3. Schematic of how contact angle measurements are taken.  
2.2.5. Characterization of cPCL and cNW surfaces 
The surface architecture of the different surfaces throughout each step in the 
immobilization process was characterized using scanning electron microscopy (SEM). Prior to 
imaging, the surfaces were coated with a 10 nm layer of gold and imaged at 5-7 kV. Surface 
morphology was investigated to ensure a stable architecture throughout the collagen 
immobilization process.  
Surface wettability was characterized by measuring the water contact angle using a 
goniometer (FTA1000 B Class) (Figure 2.3.). A 1 "L droplet of DI water was formed on the tip 
of the syringe and the stage was moved upward so that the droplet contacted and detached onto 
the surface. The water droplet image on the surface was captured within 5 secs after the contact 
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by a camera leveled with the surface. Images were then analyzed with the accompanying Fta32 
software to measure the contact angles. Images were also captured every 30 secs for 5 mins after 
contact of droplet with the surface by a camera leveled with the surface. Images were then 
analyzed with accompanying software (DROPimage advanced software) to measure contact 
angles. Each experiment was performed on three different locations on each surface and on at 
least three different surfaces after each step in the collagen immobilization on PCL and NW 
surfaces (nmin = 9) [24]. From contact angle values, surface energies were calculated using the 
equation (1):  
Equation (1):  Es = Elv cos θ  
where Elv = 72.8 mJ/m2 at 20 ºC for pure water and θ is the static contact angle [25]. Here Es is 
the surface energy of the contacting surface and Elv is the surface energy between the water and 
air under ambient conditions. 
In order to verify the presence of amine groups on PCL surfaces after aminolysis (Step 
1), ninhydrin staining was used [26]. Aminolyzed PCL and NW surfaces were first incubated in 
1.0 M ninhydrin/ethanol solution for 1 min. Surfaces were then placed in glass petri dishes with a 
cover and incubated at 37 ºC for 15 min in order to allow color to develop.  The surfaces were 
then photographed using a digital camera.  Further, a fluorescamine method was used to quantify 
the density of -NH2 groups on the surfaces after aminolysis [27]. Aminolyzed PCL and NW 
surfaces were dissolved in 2 ml 1,4-dioxane.  Once the surfaces were dissolved, 2 ml 
fluorescamine/acetone solution (1mg/ml) was added, followed by 2 ml of 2-propanol. 300 µl of 
this solution was then placed in duplicate into the wells of a white 96-well plate. Fluorescence 
intensity was measured (excitation wavelength 395 nm, maximum emission wavelength 480 nm) 
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using a microplate reader. A calibration curve was obtained with known concentrations of 1,6-
hexanediamine in the same solution to determine the density of –NH2 groups on the surfaces. 
Surface composition after each step of collagen immobilization was determined using X-
ray photoelectron spectroscopy (XPS). Survey and high-resolution C1s and N1s scans were 
taken after each step in the immobilization process in order to determine the overall 
compositional changes. The thickness of immobilized collagen on cPCL and cNW surfaces was 
determined from the attenuation of C1s peaks from the survey scans. The thickness was acquired 
by using the standard uniform overlayer model, which is given by equation (2): 
Equation (2):  
 where I0 is the intensity of C1s peaks before surface modification, I is the intensity of C1s peaks 
after immobilization with collagen, t is the thickness of the film, EL is the electron attenuation 
length for carbon peak and ! is the angle at which the X-ray hits the surface. The electron 
attenuation lengths (EL) for the carbon peak need to be calculated to obtain the film thickness 
from this equation. EL was calculated using equation (3):
Equation (3):  
where E is the electron energy (X-ray core energy – core binding energy for 
carbon) = 1486 $ 285 = 1201 eV) and " is the density of collagen (3.54 g/cm3). 
2.3. Results and Discussion 
2.3.1. Characterization Results of PCL nanowire and nanofiber surfaces 
In order to characterize the nanoarchitecture of the NW and NF surfaces, SEM imaging 
was used (Figure 2.4.). Using the image analysis system built into the SEM system, the height 
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and the diameter of the nanowires were computed to be 4.5 ± 0.5µm and 150 ± 50 nm 
respectively, while the diameter of the nanofibers was computed to be 297.9 ± 206.7 nm. The 
images show that the NW surfaces have a uniform architecture with occasional interruption in 
the uniformity by the presence of random microchannels formed due to surface charge effects. 
Previous studies have shown that similar NW and NF surfaces enhance cellular functionality [22, 
28, 29].  
The hydrophilic nature of the nanostructured surfaces was characterized by contact angle 
measurements of DI water using a sessile drop measuring technique. The contact angle is defined 
as the angle between the surface and the tangent line at the point of contact of the DI water 
droplet with the surface [24]. Higher surface energy is associated with hydrophilic surfaces, 
whereas lower surface energy is associated with hydrophobic surfaces. Further, it is well known 
that increased surface energy improves the interaction between the surface and the biological 
environment such as increased cell spreading on the surface [30]. The results indicate that the 
NW surfaces (71.9 ± 3.3º) are more hydrophilic compared to the NF surfaces (98.2º± 6.4º) and 
PCL surfaces surfaces (84.7 ± 1.5º) (Figure 2.5.).   
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Figure 2.4. Representative SEM images of (A) PCL, (B and C) NW and (D and E) NF 
surfaces. 
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Figure 2.5. Contact angle measurements of PCL, NW and NF surfaces indicating 
hydrophillic/ hydrophobic nature of the surfaces. Significantly different contact angle 
measurements were seen on all three surfaces (@, #, *% p < 0.05). 
Total surface energy can be defined as the surface area times the specific surface energy. 
Due to the fact that all three surfaces are fabricated from PCL, the specific surface energy is 
constant. Thus the total surface energy is solely dependent on the surface area. The nano-
architecture on NW contributes to a higher surface area compared to the PCL surface. The 
surface of the NF surfaces is PCL fibers that do not cover as much area as the PCL surfaces do. 
Therefore the total surface energy from high to low should be NW, PCL followed by NF. This is 
consistent with contact angle measurements because a high surface energy corresponds to a 
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lower contact angle. Therefore, by simply changing the topography, the surface energy can be 
altered, thus altering the biological response. 
 
2.3.2 Characterization Results of cPCL and cNW surfaces 
The surface architecture of PCL and NW surfaces was characterized using SEM after 
each step of collagen immobilization (Figure 2.6.).  The unmodified PCL and NW surfaces have 
been previously characterized in section 2.3.2. [16]. After each step of modification, the SEM 
images indicate no significant changes as compared to unmodified surfaces. Further, it is evident 
that the NW surfaces maintain their nanoarchitecture throughout the immobilization process.  
Surface wettability was characterized after each step of collagen immobilization by 
measuring the water contact angle. The results indicate that the surfaces are significantly more 
hydrophilic after -NH2 modification and collagen immobilization for both PCL and NW surfaces 
as compared to unmodified surfaces (Figure 2.7.(a)). Further, the NW surfaces before and after -
NH2 modification and collagen immobilization were significantly hydrophilic compared to PCL 
surfaces before and after NH2 modification and collagen immobilization. Surface energies were 
then calculated from the contact angle measurements using equation (1) (Figure 2.7.(b)). Results 
indicate that both PCL and NW surfaces show increase in surface energy after each step of 
collagen immobilization process, however NW surfaces have a higher surface energy due to the 
fact that they have more surface area than PCL. Studies have shown enhanced cell adhesion on 
surfaces with high energies [30, 31]. Furthermore, it has been suggested that nano- and 
submicron surface patterns with high surface energy can affect the endothelial cell adhesion 
while retaining bulk material chemistry [32]. Therefore it is hypothesized that a high surface 
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energy will promote the adherence of anchorage dependent endothelial cells while enhancing 
matrix production. 
Figure 2.6. Representative scanning electron microscopy images of PCL and NW surfaces after 
each step of immobilization process (unmodified, + NH2, + Collagen). 
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Figure 2.7. (a.) Contact angle measurements on PCL and NW surfaces after each step of 
immobilization process (unmodified, + NH2, + Collagen). Experiments were performed on at 
least three different samples at three different locations (nmin = 9). Unmodified, + NH2 and + 
Collagen surfaces (for both PCL and NW) were all statistically different (p < 0.05). Error bars 
represent standard deviation.  (b.) Surface energies calculated from contact angle measurements 
for PCL and NW surfaces after each step of immobilization process (unmodified, + NH2, + 
Collagen). Unmodified, + NH2 and + Collagen surfaces (for both PCL and NW) were all 
statistically different (p < 0.05). Error bars represent standard deviation. 
Water contact angles were also determined over a course of 5 mins. Contact angle is 
defined as the angle between the liquid/solid interface [33]. The results indicate significantly 
different contact angles between all four surfaces that were evaluated (Figure 2.8.). PCL 
surfaces have the highest contact angle, followed by NW and cPCL surfaces with cNW surfaces 
having the lowest contact angle. Further, the contact angles on all the surfaces decreased after 5 
mins of contact with water droplet. However, the contact angle on cNW surfaces dropped within 
few seconds of contact with water droplet, indicating that the surface is extremely hydrophilic. 
Contact angles are dependent on surface area as well as specific surface properties such as 
polarity. The lower surface areas on PCL and cPCL surfaces attribute to the higher contact 
!"# $"#
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angles compared to those on NW and cNW surfaces. Further collagen coating the surfaces 
decreases contact angle due to an increase in polar groups immobilized to the surface. 
 
Figure 2.8. Contact angle measurements of PCL, NW, colPCL and colNW surfaces taken every 
30 secs for 5 mins. Results indicate significant differences in contact angles on all surfaces 
(PCL>NW>colPCL>colNW) (p<0.05).  Experiments were replicated with at least three different 
cell populations on at least three different samples (nmin = 9). Error bars represent standard error. 
In order to verify the presence of amine groups on PCL surfaces after aminolysis (Step 
1), ninhydrin staining was used. Results indicate that -NH2 groups are evenly distributed on both 
PCL and NW surfaces that were aminolyzed as indicated by the uniform purple color on surfaces 
(Figure 2.8). No purple color was observed on unmodified PCL and NW surfaces indication no -
NH2 groups were present on the surfaces.  Further, a fluorescamine method was used to quantify 
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the density of -NH2 groups on the surfaces after aminolysis. The results indicate significantly 
higher -NH2 density on NW surfaces as compared to PCL surfaces after aminolysis (Figure 2.9.). 
The increase in -NH2 density can be explained due to the increased surface area of NW surfaces.  
The increase in surface area provides –NH2 groups with more reactive sites to adhere to. 
Figure 2.9. Representative images of PCL and NW surfaces before and after aminolysis stained 
with ninhydrin. The graph shows quantification of NH2 groups on PCL and NW surfaces before 
and after aminolysis measured using fluorescamine method. Experiments were performed on at 
least nine different samples (nmin = 9). Unmodified PCL and NW surfaces did not show presence 
of NH2 groups on the surface as compared to the surfaces that were aminolyzed. Error bars 
represent standard deviation. 
Surface composition after each step of collagen immobilization was determined using 
XPS. Survey and high-resolution C1s and N1s scans were taken after each step in the 
immobilization process in order to determine the overall compositional changes.  The survey and 
high-resolution N1s scans indicate increasing amounts of nitrogen on both PCL and NW surfaces 
after aminolysis and collagen immobilization (Figure 2.10. and 2.11.(a)).  Similarly, the high-
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resolution C1s scans indicate increasing amounts of carbon on both PCL and NW surfaces after
aminolysis and collagen immobilization. (Figure 2.11.(b)).  Further, the thickness of 
immobilized collagen on cPCL and cNW surfaces was determined from the attenuation of C1s 
peaks from the survey scans. The thickness was acquired by using the standard uniform 
overlayer model, which is given by equation (2).  The thickness of collagen layer was 
approximately 1.56 nm on NW surfaces as compared to 1.65 nm on PCL surfaces, indicating 
similar film thickness on both surfaces. 
Figure 2.10. Survey XPS scans of PCL, NW, colPCL and colNW surfaces. Results show an 
increase in the N1s peak throughout the collagen immobilization process.  
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Figure 2.11. Representative high-resolution (a) N1s and (b) C1s XPS scans on PCL and NW 
surfaces after each step of immobilization process. 
2.4. Conclusions 
The surface properties of implantable cardiovascular devices are critical for long-term 
success. This research has investigated the characteristics of similar sized features that are 




to the surface. Further characteristics of collagen immobilized surfaces were also elucidated. 
These characteristics were evaluated using SEM, contact angle and XPS. 
Polycaprolactone NFs were fabricated with an electrospinning technique and a novel 
solvent-free template synthesis technique was used to fabricating controlled arrays of high aspect 
ratio, substrate-bound NWs. Surfaces were immobilized with collagen utilizing an aminolysis 
method. The resulting SEM images show the production of either horizontally oriented, uniform 
NFs or vertically oriented, high aspect ratio and uniform NWs. Immobilizing collagen to the 
surfaces did not significantly alter the surface topography. Further, results identify a highly 
hydrophobic NF surface, while NW surfaces exhibit a more hydrophilic surface. The 
immobilization of collagen on the surfaces further decreases the contact angle. The simple 
fabrication, physiologically relevant architecture, low contact angle large surface area identify 
nanowire surface as promising interfaces for implantable biomedical devices. Further studies are 
now targeted towards understanding the effects of altered extrusion temperatures and membrane 
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HEMOCOMPATIBILITY OF POLYMERIC NANOSTRUCTURED SURFACES 
 
3.1. Introduction 
Cardiovascular disease is the leading cause of death worldwide killing 17.3 million 
people a year [1]. Current treatments for cardiovascular diseases include organ transplants, 
surgery, metabolic products and mechanical/synthetic implants [2]. Of these, mechanical and 
synthetic implants have shown great promise in recent years. Metals, natural polymers and 
synthetic polymers have been used in these mechanical and synthetic cardiovascular 
implants [3,4]. However, synthetic polymers have been recognized as better candidates for 
cardiovascular repair due to the thrombogenic nature of metals and limit in processability of 
natural poly- mers [5,6]. In particular, synthetic polymers such as polyurethane [7], poly(L-
lactic acid) [8], polyglycolic acid [9] and polycaprolactone (PCL) [10] have proven to be of 
tremendous use due to their biocompatibility and controlled mechanical properties. These 
polymers have been used to develop cardiovascular devices such as vascular grafts [11], 
artificial hearts [12], and heart valves [13], all of which have been widely used in recent years 
[14]. These implants have the potential to replace the damaged components of the 
cardiovascular system, while maintaining the normal tissue function. Tissue integration is 
important property when inducing transplant tolerance, however, the hemocompatibility of the 
biomaterial surface also plays an important role in the ultimate success of the implant. 
Therefore, in order to induce transplant tolerance, it is critical to understand the interaction of 
blood components with the material surfaces [15,16]. Hemocompatibility is an essential 
property of biomaterials and can be measured by the interaction between the material and the 
!
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various blood components, such as blood plasma proteins, erythrocytes, platelets and 
leukocytes [17]. Lack of hemocompatibility can lead to either rejection and/or loss of function 
[18] initially through the activation of the blood coagulation cascade followed by initiation of 
immune responses [19]. Blood reactions occur as a result of the physical and chemical 
properties of implant surface, therefore tolerance can potentially be achieved by altering the 
biomaterial surface properties [20]. 
When a biomaterial is implanted inside the body, proteins are adsorbed on the material 
surface [21], followed by platelet adhesion and activation, eventually leading to the formation 
of thrombus [22]. Previous work has investigated various surface modifications strategies to 
alter the hemocompatibility of biomaterial surfaces [23–25]. Inorganic and organic coatings 
[26], polymer surface chemical modification [27], and chemically patterned surfaces [28] have 
been used to alter hemocompatibility. These surfaces have proven to produce favorable 
hemocompatible response through inertness, chemical and mechanical stability, and low protein 
adsorption [19,28]. Unfortunately, these surfaces are not stable when exposed to the shear 
stresses of blood flow [29], thus it is important to have a robust surface that can withstand 
physiological forces. The hierarchy of the natural tissue extracellular matrix (ECM), from nano 
to macro scale, has inspired fabrication of surfaces with different topographies. In recent 
years, nanostructured surfaces have emerged as a potential solution to improve material 
integration with the tissue. Studies have shown that surfaces that mimic the ECM 
nanotopography can promote tissue integration and regeneration [30]. Thus, polymers with 
tunable properties have been extensively researched. Polymeric nanostructured surfaces have 
shown to affect cellular growth and functionality [31–33]. In particular, these surfaces have 
demonstrated improved fibroblast cell adhesion [34], neuronal cell differentiation [35], and 
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osteoblast phenotypic activity [19,36]. However, it is unclear how these polymeric 
nanostructured surfaces interact with the blood and its components. An understanding of 
blood/nanomaterial interaction is essential to understand how transplant tolerance is induced 
using nanostructured surfaces. 
In this study, we have investigated the hemocompatibility of two different 
nanostructured surfaces: nanowires (NWs) and nanofibers (NFs). These two nanotopographies 
were chosen because they have similar sized features that are aligned differently; NWs are 
aligned perpendicular to the surface while NFs are aligned parallel to the surface. It is 
hypothesized that this alteration in the alignment of nanostructures on the surface will result 
in a very different response to blood components, thus altering the hemocompatibility. PCL 
was chosen as the material since it is a bioresorbable polyester with exceptional mechanical 
strength and low degradation rate [37]. PCL scaffolds have been used extensively in many 
tissue engineering applications, specifically for vascular tissue [38,39], bone and cartilage 
[40,41], nerve [42,43], dental [44] and skin [45]. The low degradation rate of PCL is favorable 
for long-term implants [46,47]. Further, degradation products of PCL in the body can be 
removed naturally by the metabolic pathways [3,37,48] eliminating the possibility of foreign 
body reactions. PCL can also be processed into unique nanostructured surfaces such as NWs 
[49], thin film NWs [50], nano-fibrous networks [51] and NFs [52–54]. These nanostructured 
features are capable of being tuned. For example, electrospinning has shown promising 
results with its ability to fabricate surfaces that mimic the ECM hierarchy. By changing 
electrospinning parameters such as voltage, working distance and polymer  concentration,  the  




To evaluate interactions at the blood-nanomaterial interface, it is necessary to 
understand the events that occur during the introduction of a foreign object inside the body. 
Driven by a need for understanding potential biomedical and clinical uses of PCL 
nanostructured surfaces, this work specifically looks at the earliest stages of blood-material 
interaction by considering the in vitro adsorption of key blood serum proteins, adhesion and 
activation of platelets and clotting kinetics of whole blood. In this study blood serum protein 
adsorption on nanostructured surfaces was investigated using a colorimetric assay and X-ray 
photoelectron spectroscopy (XPS). Fluorescence microscopy and scanning electron microscope 
(SEM) were used to determine the adhesion and activation of platelets. A simple hemolysis 
assay was used to investigate the whole blood clotting kinetics. It was found surfaces 
fabricated from the same material PCL with altered nanotopography orientation, induce 
different hemocompatible response. 
 
3.2. Materials and methods 
3.2.1. Fabrication and characterization of PCL NW and NF surfaces 
Surfaces were fabricated and characterized as described in detail in section 2.2.1 and 
2.2.2. The nanowire surface architecture was examined for uniformity and repeatability using 
SEM imaging.  
 
3.2.2. Protein adsorption on PCL NW and NF surfaces 
 In order to understand how key blood serum proteins interact with the nanostructured 
sur- faces; albumin (ALB), fibrinogen (FIB) and immunoglobulin-G (IgG) (Sigma) adsorption 
was investigated on PCL, NW and NF surfaces. Sterilized surfaces were incubated in a 24-
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well plate with 100 μg/ml solution of ALB, FIB and IgG in PBS on a horizontal shaker 
plate (100 rpm) at 37 °C and 5% CO2. After 2hrs of incubation, the protein solution was 
aspirated followed by 3 rinses with PBS to remove any non-adherent proteins. The protein 
adsorption was measured using a commercially available micro-BCA assay (Pierce 
Biotechnology) and the adsorbed protein on nanostructured surfaces was visualized by SEM 
imaging. 
In order to measure the protein adsorption using micro-BCA assay, all the surfaces 
were transferred to a fresh 24-well plate and incubated with 1% sodium dodecyl sulfate 
(SDS) solution (SDS, Sigma) in PBS on a horizontal shaker plate (100 rpm) for 1hr. 
Following incubation, the excess SDS solution with solubilized proteins was collected from 
each well. The SDS incubation was repeated 2 more times and the resulting SDS solution 
with solubi- lized proteins was pooled. The concentration of the total adsorbed protein in the 
pooled SDS solution was then measured colorimetrically using a micro-BCA assay with a plate 
reader. 
XPS (XPS, ESCASystems X-ray Photoelectron Spectrometer 5800) was used to 
determine the surface composition of  adsorbed  proteins on  nanostructured surfaces. High-
resolution spectra were collected for C1s peak with a pass energy of 10 eV. Peak fit analysis was 
performed using Multipack and XPSPeak 4.1 (Freeware) software. 
Further, the protein adsorbed nanostructured surfaces were air dried and coated with 






 3.2.3. Platelet isolation from whole blood 
 Whole blood from healthy individuals, acquired through venopuncture, was drawn into 
standard 6 ml vacuum tubes coated with the anti-coagulant, ethylenediaminetetra acetic acid 
(EDTA). The first tube was discarded to account for the skin plug and locally activated 
platelets resulting from the needle insertion. The blood vials were centrifuged at 150 g for 15 
min to separate the plasma from the red blood cells (erythrocytes). The plasma was then 
pooled into fresh tubes, and used within 2 h. 
 
 3.2.4. Platelet adhesion and viability on PCL NW and NF surfaces 
 Sterilized PCL, NW and NF surfaces were incubated in a 24-well plate with 1,000 
μl of pooled plasma at room temperature on a horizontal shaker plate (100 rpm) for 2 h. The 
effects of the surface nanoarchitecture on  platelets  adhesion and  viability were  investigated  
and compared to that on the control surface. 
Platelet adhesion was characterized by staining the cells with calcein-AM (Invitrogen) 
live stain. Prior to staining, the un-adhered platelets were removed by aspirating the plasma 
from the surfaces followed by rinsing with PBS. The surfaces were incubated with 2 μM 
calcein- AM solution in PBS for 30 min on a horizontal shaker plate (100 rpm) at room 
temperature. The surfaces were then rinsed with PBS and imaged with a fluorescence 
microscope using appropriate filters. Further, the fluorescence microscopy images were 
analyzed using ImageJ software to calculate the number of adhered platelets on surfaces. 
Platelet viability was characterized using a commercially available MTT assay kit. 
Through the use of bicinchoninic acid (BCA), this assay detects the cuprous ion (Cu+1), 
which forms when Cu+2 is reduced by protein. The chelation of two molecules of BCA with 
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one cuprous ion forms a purple reaction product that exhibits a strong absorbance at 562 nm. 
The production of Cu+1 is directly proportional to the concentration of the protein and the 
incubation time in BCA. Thus, protein concentration can be calculated using a standardized 
protein curve. Prior to measuring the MTT activity, the un-adhered platelets were removed by 
aspirating the plasma from the surfaces followed by rinsing with PBS. The nanostructured 
surfaces were incubated with 10% MTT solution in hepes-tyrode buffer for 4hrs on a 
horizontal shaker plate (100 rpm) at room temperature. The resulting formazan crystals were 
dissolved by adding MTT solvent in the amounts equal to the hepes-tyrode buffer. The 
absorbance of the solution was measured using a plate reader. 
 
 
3.2.5. Platelet activation on PCL NW and NF surfaces 
Sterilized PCL, NW and NF surfaces were incubated in a 24-well plate with 1,000 μl of 
pooled plasma at room temperature on a horizontal shaker plate (100 rpm) for 2 h. Un-adhered 
platelets were removed by aspirating the plasma from the surfaces followed by rinsing with PBS. 
Platelet activation on nanostructured surfaces was visualized using SEM imaging. The platelets 
were fixed by incubating the surfaces in a solution of primary fixative (3% glutaraldehyde 
(Sigma), 1.1 M sodium cacodylate (Polysciences), and 0.1 M sucrose (Sigma) for 45 min. 
This was followed by incubation in a solution of secondary fixative (primary fixative without 
gluteralde- hyde) for 2 h. This was followed by a dehydration step where the surfaces were 
incubated in consecutive solutions of ethanol (35, 50, 70, 95, and 100%) for 10 min. Further 
dehydration of the platelets was accomplished by incubating the surfaces in 
hexamethyldisilazane (HMDS, Sigma) for 10 min. The surfaces were coated with a 10 nm layer 
of gold and imaged at 5–7 kV. The SEM images were then used to determine the percentage of 
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the adhered platelets that were unactivated, or had a short-dendritic or a long-dendritic 
morphology. The following scheme was used to determine the morphology of the platelets: 
• Unactivated: Platelets that are normal and with compact central body. 
• Short-dendritic: Platelets with smaller dendrites and partially activated. 
• Long-dendritic: Platelets with many long dendrites and completely activated. 
 
3.2.6. Whole blood clotting on PCL NW and NF surfaces 
Sterilized PCL, NW and NF surfaces were transferred to a 24-well plate to evaluate 
whole blood clotting kinetics. Whole human blood from healthy individuals was drawn, and 5 
μl of the blood was immediately dropped on the surfaces. The blood was allowed to clot for up 
to 60 min, and the free hemoglobin concentration was measured at 15 min intervals. In order to 
measure the free hemoglobin concentration, the surfaces were transferred into a different 
24-well plate with 500 μl of DI water. The surfaces were gently agitated for 30 s and left in 
the DI water for 5 min to release free hemoglobin from red blood cells that were not trapped in 
the thrombus. The absorbance of the DI water with free hemoglobin was measured at a 
wavelength of 540 nm using a plate reader. The value of absorbance is directly proportional to 
the concentration of free hemoglobin in DI water. Further, the surfaces were air dried, 
coated with a 10 nm layer of gold and imaged with SEM at 5–7 kV. 
 
 
3.2.7. Statistical analysis 
Each experiment was reconfirmed on three different surfaces of each PCL, NW and NF 
with at least three different platelet populations (nmin = 9). The protein adsorption results 
were confirmed on three different surfaces of each PCL, NW and NF with at least two 
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repetitions (nmin = 6). All the quantitative results were analyzed using t-test. Statistical 
significance was considered at p < 0.05. 
 
3.3. Results and discussion 
 Current treatments for cardiovascular disease include organ transplants, surgery, 
metabolic products and mechanical/synthetic implants. However, rejection of cardiovascular 
implants continues to be a problem, eliciting a need for understanding the mechanisms behind 
tissue– material interaction. Recently, there has been an increased interest in exploring 
nanostructured surface topographies as interfaces for implantable devices. Several studies have 
reported favor- able cellular response on such nanostructured topographies, however few 
studies report the hemocompatibility of these surfaces. In this work, we have evaluated the 
hemocompatibility of NW and NF surfaces fabricated by nano-templating method and 
electrospinning respectively. 
 
3.3.1. Fabrication and characterization of PCL NW and NF surfaces 
 In order to characterize the nanoarchitecture of the NW and NF surfaces, SEM imaging 
was used (Figure 3.1.). Using the image analysis system built into the SEM system, the 
height and the diameter of the NWs (Figure 1(B) and (C)) were computed to be 4.5 ± 0.5 μm 
and 150 ± 50 nm respectively, while the diameter of the NFs was computed to  be  290 ± 200 nm 
(Figure 1(D) and (E)). The images show that the NW surfaces have a uniform architecture 
with occasional interruption in the uniformity by the presence of random  microchannels formed 
due to surface charge effects. Previous studies have shown that similar NW and NF surfaces 









3.3.2. Protein adsorption on PCL NW and NF surfaces 
 When a biomaterial is implanted, proteins from the blood and surrounding tissue are 
adsorbed onto the surface within seconds to minutes. Protein adsorption is an active process 
where the surface characteristics presented dictate the differing quantities, densities, 
conformations and orientations of which proteins adsorb [62]. Further biological processes, such 
as activation of coagulation and inflammation cascades are impacted by the early adsorption of 
blood serum proteins. Therefore, the effect of protein adsorption on nanostructured surfaces is 
an important indicator of blood compatibility. 
In this study, adsorption of key blood serum proteins, ALB, FIB and IgG was assessed 
on nanostructured surfaces. ALB is the main protein in blood plasma that functions mainly to 
regulate and maintain colloidal osmotic pressure of blood. It is a globular protein and may be 
distorted upon interaction with the surface.[62] FIB is a plasma glycoprotein that plays a key 
role in the inflammatory response by assisting in clot formation. It forms a Y shaped structure 
with two identical halves (Fab) linked by a globular domain in the center (Fc).[62] IgG is the 
main antibody isotype found in the blood that functions to control infection of body tissues. It 
also exhibits a Y shaped formation, similar to that of FIB, however it is not as elongated as 
FIB. The amount of protein adhered on the surfaces were determined using two different 
methods: a micro-BCA assay and XPS surface analysis. The micro-BCA assay was used to 
measure the total protein adsorption (bulk plus surface), whereas XPS was used to measure 
the surface protein adsorption. The adsorbed proteins on the nanostructured surfaces were 
further visualized using SEM. 
In order to evaluate the total protein adsorption, the proteins adsorbed on the 
surfaces were desorbed using an anionic detergent, SDS and their amounts  were evaluated using 
!
! 69 
micro-BCA assay. The results indicate no significant differences in ALB adsorption on all the 
surfaces (Figure 3.2.). However, FIB and IgG adsorbed significantly more on NW, followed by 




Figure 3.2. Overall blood serum protein adsorption on PCL, NW and NF surfaces determined 
by micro- BCA assay. Note: No significant differences in ALB adsorption on PCL, NW and 
NF surfaces. Significant differences in FIB adsorption on PCL and NF surfaces, and NW and 
NF surfaces (p < 0.05). Significant differences in IgG adsorption on all surfaces (p < 0.05). 
 
 In order to evaluate the surface protein adsorption, high-resolution C1s scans were 
taken using XPS. The high resolution C1s peak consists of three sub-peaks: C–C, C–N and N–
C=O. A precise way to characterize proteins adsorbed on the surface is to determine the 
contribution of N–C=O (amide) peak (the N–C=O peaks is at a shift 1.8 eV from the C–C 
peak) in the overall C1s peak. (Figure 3.3. and Table 3.1.). The results indicate that all the 
three surfaces had similar contribution of N–C=O peak for ALB adsorption, indicating 
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similar amounts of ALB adsorbed on all the surfaces. However, NF surfaces had higher 
contribution of N–C=O peak for both FIB and IgG adsorption, indicating higher FIB and IgG 
adsorption compared to that on NW and PCL surfaces.
 
Figure 3.3.   High resolution C1s scans for surfaces adsorbed blood serum proteins on PCL, 
NW and NF surfaces showing C–C, C–N and N–C=O for ALB, FIB and IgG. 
Table 3.1. Adsorption of key blood serum proteins ALB, FIB and IgG were investigated on
PCL, NW and NF surfaces. The contribution of C–C, C–N and N–C=O peaks in the overall




 The results obtained from XPS are in contrast with that from micro-BCA assay. 
This can be explained based on variations in the surface nanotopography as well as the 
structure of the protein and how it is adsorbed on different nanostructured surfaces. It is 
evident from SEM images (Figure 1) that nanostructured surfaces at a nanoscale level can be 
considered to have a three-dimensional structure. In case of NW surfaces, this three-
dimensional structure can be visualized due to the presence of gaps between the individual 
NWs as well as the microchannels that are formed due to the surface tension interaction during 
the membrane dissolution process. The proteins will not only adsorb on the surface of 
NWs, but also may penetrate through the three-dimensional structure and adsorb into the gaps 
and the microchannels. In case of NF surfaces, the three-dimensional structure can be 
visualized as an interconnected porous network formed by continuous NFs that are present 
through the bulk of the substrate. The proteins will  not  only  adsorb  on  the  surface  of  NF,  
but  also may infiltrate into the interconnected porous network and adsorb on the fibers 
beneath the surface. In case of PCL surfaces, the lack of any surface nanoarchitecture limits 
the proteins adsorption to the surface. 
The results indicate that total as well as surface ALB adsorption was similar on all 
three nanostructured surfaces. ALB is a globular protein  that  is  typically  more  hydrophobic 
than hydrophilic.[63] This may prevent the protein molecules from infiltrating into the three-
dimensional structure of the nanostructured surfaces. Thus, all the ALB adsorbed on the 
surface similar to that of the PCL surface. This resulted in similar trends in total and 
surface ALB adsorption on nanostructured surfaces. In contrast, FIB and IgG adsorption 
was different on different surfaces. Further, the results indicate that NW surfaces had higher 
total FIB and IgG adsorption compared to NF and PCL surfaces. In contrast, NW surface 
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had lower surface FIB and IgG adsorption compared to NF and PCL surfaces. This can be 
explained based on the structure of FIB and IgG as well as the ability of the surfaces to 
allow protein infiltration. Both FIB and IgG have a  planar  Y  shape  structure,  with  FIB being 
more elongated then IgG. Studies have shown that FIB [62] and Fc portion of IgG [64–66] 
is more attracted to hydrophobic surfaces. Due to the Y shape structure of both FIB and 
IgG as well their tendency to be less attracted towards hydrophilic surfaces, the protein 
molecules will adsorb less on the NW  surfaces.  However, the  protein  molecules may still 
penetrate through the three-dimensional structure and adsorb into the gaps and the 
microchannels, resulting in higher total protein adsorption on NW surfaces due to the avail- 
ability of higher surface area for protein molecules to interact. In contrast, NF surfaces are 
more hydrophobic then NW surfaces, resulting in higher surface FIB and IgG adsorption. 
However, due to the interconnected porous network formed by continuous NFs and the Y 
shape of both FIB and IgG, the protein molecules may not be able to infiltrate that easily 
into the three-dimensional structure, resulting in lower total FIB and IgG adsorption on NF 
surfaces as compared to NW surfaces. In case of PCL surfaces, the lack of nanotopography 
resulted in all the protein adsorbed on the surface and total protein adsorption is equal to 
the surface protein adsorption. 
Adsorbed proteins on the nanostructured surfaces were also visualized using SEM 
(Figure 3 . 4.). As expected, all the proteins that were adsorbed on PCL surfaces 
crystalized, whereas, the proteins adsorption was uniform on both NW and NF surfaces. This 





 Figure 3.4.   Representative SEM images of ALB (A, D and G), FIB (B, E and H) and IgG 
(C, F and I) adsorbed on PCL (A–C), NW (D–F) and NF (G–I) surfaces. 
 
3.3.3. Platelet adhesion and viability on PCL NW and NF surfaces 
Platelet adhesion on a surface triggers the coagulation of blood and therefore is an 
important indicator of thrombogenecity. In this study, platelets were isolated from whole 
human blood and their adhesion on nanostructured surfaces was investigated after 2 h of 
contact time. The platelets were stained with calcein-AM and the surfaces were examined 
under a fluorescence microscope to evaluate the platelet adhesion. The results indicate 
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significantly higher platelet adhesion on NF surfaces followed by PCL surfaces and NW 
surfaces (Figure 3 . 5.). Further, high-magnification images reveal that platelets are clustering 
and probably infiltrating in the NF surfaces (Figure 6(G)–(I)). In contrast, the platelets on PCL 
and NW surfaces do not form clusters (Figure 6 PCL: A, B and C; NW: D, E and F). 
Further, low magnification (10x) fluorescence microscopy images were analyzed 
using ImageJ software to determine the number of platelets adhered on different surfaces. 
The results indicate significantly higher platelet adhesion on NF surfaces followed by PCL 
surfaces and NW surfaces (Figure 3.6.). Platelet adhesion results were consistent with  the 
protein adsorption results. The NF surfaces had higher surface FIB adsorption compared to 
PCL and NW surfaces resulting in higher platelet adhesion. This is consistent with recent 
work demonstrating higher platelet adhesion and activation on NF surfaces [67]. 
Platelet viability was evaluated using an MTT assay. The MTT assay determines the 
amount of mitochondrial activity in  the live  cells via  dehydrogenase activity. This assay 
measures the absorbance of formazan, which is reduced by MTT in living cells. Therefore, 
the amount of adhered platelets directly corresponds to the absorbance values of formazan. 
The results indicate significantly higher platelet viability on NF surfaces as compared to PCL 
and NW surfaces, indicating higher number of platelets present on NF surfaces (Figure 






Figure 3.5.   Representative fluorescence microscopy images of adhered platelets stained with 






Figure 3 . 6. Number of adhered platelets on PCL, NW and NF surfaces calculated using 
fluorescence microscopy images and ImageJ software. Significant differences in number of 




Figure 3 .7. MTT assay results indicating viability of adhered platelets on PCL, NW and NF 
surfaces. Significant differences in viability of platelets adhered on PCL and NF surfaces (@ 
→ p < 0.05), and NW and NF surfaces (*→ p < 0.05). 
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3.3.4. Platelet activation on PCL NW and NF surfaces 
  Once plasma proteins adsorb on a biomaterial surface, a series of biochemical events 
that cause platelet adhesion and activation is initiated. Activated platelets trigger the 
activation of plasma coagulation factors which lead to the generation of a fibrin clot.[68] 
Platelet activation after 2 h of contact time with nanostructured  surfaces  was  investigated  
with SEM imaging. The nanostructured surfaces were coated with  a 10 nm layer of gold 
and imaged at 5–7 kV. The SEM images at low magnifications indicate significantly higher 
number of platelets on NF surfaces followed by PCL surfaces and NW surfaces (Figure 




Figure 3.8.   Representative SEM images of adhered platelets on PCL (A–C), NW (D–F) and 
NF (G–I) surfaces. 
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High magnification SEM images reveal significant morphological differences in 
platelets adhered on the different surfaces. The SEM images were used to determine the 
percentage of adhered platelets that were unactivated or had a dendritic (short-dendritic or 
long-dendritic) morphology (Figure 3.9.). The results show NF surfaces with a higher 
percentage of platelets with long-dendritic morphology (~50%) indicating complete activation, 
followed by platelets with short-dendritic morphology (~30%), and fewer platelets with 
unactivated morphology (~20%). In contrast, PCL surfaces has higher percentage of 
platelets with short-dendritic morphology (~56%), followed by platelets with unactivated 
morphology (~23%), and fewer platelets that are completely activated (~21%). NW surfaces 
have a higher percentage of platelets with a n  unactivated morphology (~55%), followed by 
platelets with short-dendritic morphology (~27%), and fewer platelets exhibiting long-
dendritic morphology (~17%). It is important to note that PCL and NW surfaces can 
potentially activate platelets as the clotting cascade progresses despite the fact that they do 
not support significant platelet adhesion. Furthermore, these results indicate the importance 






Figure  3.9.   Distribution  of  different  shapes  of  adhered  platelets  on  PCL,  NW  and  NF  
surfaces. Representative morphology of platelets shown below the graph. 
 
3.3.5. Whole blood clotting on PCL NW and NF surfaces 
Following platelet adhesion and activation, the next step in the cascade of blood 
coagulation is the formation of a fibrin matrix. The kinetics of whole blood clotting is 
important in determining the success of a long-term blood contacting material. If a clot forms 
abruptly tissue integration will be inhibited. The results indicated that blood clotted on all 
surfaces within 1hr of exposure, however the rate of clotting was different for different 
surfaces (Figure 3.10.). After 30 min of clotting, there were significant differences in the 
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amount of free hemoglobin in the blood that was in contact with NW surfaces indicating 
least clotting on the surface, followed by NF and PCL surfaces. Further, increased amounts 
of free hemoglobin were in the blood that was in contact with NW surfaces compared to 
both PCL and NF surfaces throughout the entire clotting process. These results are 
consistent with platelet activation studies as well as surface FIB adsorption. 
The blood clotting cascade is initiated by the enzyme thrombin, which converts FIB 
into fibrin, eventually forming a clot network. The fibrin network after 60 min of clotting 
time on PCL, NW and NF surfaces was examined using SEM imaging. Visual inspections 
show the fibrin matrix formation to be altered on all three surfaces (Figure 3.11.). Due to 
the hydrophobic nature of PCL surfaces, the blood drop did not spread when it contact with the 
surface, resulting in well-defined blood-PCL interface (Figure 12(A)–(C)). In contrast, due to 
the hydrophilic nature of the NW surface, the blood drop spread on the surface and infiltrated 
the nanoarchitecture, resulting in a ‘gradient-like’ blood-NW interface (Figure 12(D)–(F)). 
However, due to the porous nature of NF surfaces, the blooddrop completely infiltrated in the 







Figure 3.10. Free hemoglobin concentration determined in terms of its absorbance on PCL, 
NW and NF surfaces for 60 min of clotting time. Significant differences in free hemogloblin 
concentrations after 15 min on NW and NF surfaces, and NW and PCL surfaces (*, # → 
p<0.05). Significant differences in few hemogblobin concentrations after 30 mins on all 




Figure 3 .11.   Representative SEM images of whole blood clotted on PCL (A–C), NW (D–
F) and NF (G–I) surfaces. 
 
3.4. Conclusion 
Recently, there has been an increased interest in exploring nanostructured surface 
topographies as interfaces for implantable devices. Several studies have reported favorable 
cellular response on different nanostructured topographies, however few studies report the 
hemocompatibility of these surfaces. In this work, we have evaluated the hemocompatibility of 
NW and NF surfaces fabricated by nano-templating method and electrospinning respectively. 
The results indicate no significant differences in ALB adsorption on all surfaces. However, NW 
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surfaces had higher total FIB and IgG adsorption compared to NF and PCL surfaces. In contrast, 
NW surfaces had lower surface FIB and IgG adsorption compared to NF and PCL surfaces. This 
can be explained based on the structure of FIB and IgG as well as the ability of the surfaces to 
allow protein infiltration. Platelet adhesion and viability studies show a large amount of 
adhesion and clustering of platelets on the NF surfaces as compared to PCL and NW surfaces. 
Platelet activation studies reveal that NW surfaces have the highest percentage of unactivated 
platelets, whereas NF surfaces have the highest percentage of fully activated platelets. Whole 
blood clotting results indicate that NW surfaces maintain an increased amount of free 
hemoglobin during the clotting process compared to PCL and NF surface, indicating less 
clotting and slower rate of clotting on their surfaces. The results presented here indicate that 
the surface nanoarchitecture and how it is presented to the biological environment can 
modulate the hemocompatibility. Further studies are now directed towards evaluating the 
effects of altered lengths and diameters of nanofeatures on hemocompatibility and specific 
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In order to create an optimal cardiovascular scaffold design, it is critical to understand 
the events that occur at the cardiovascular tissue-material interface. In particular human vascular 
endothelial cells are important to study due to the fact that they form an interface between 
circulating blood and the rest of the vessel wall. Vascular endothelial cells line the entire interior 
of the circulatory system and have very distinctive functions such as filtering fluids, hemostasis, 
hormone trafficking and regulating blood pressure by synthesizing nitric oxide [1, 2]. 
Furthermore, the success of cardiovascular implants is associated with the development of an 
endothelium formed by endothelial cells, which is critical with the prevention of intimal 
hyperplasia, calcification and thrombosis [3]. A thorough understanding of the interaction 
between vascular endothelial cells and the biomaterial involved is essential in order to have a 
successful application which promotes healing and regeneration through integration with native 
tissue. One major obstacle to overcome is adhering the anchorage-dependent and slowly 
renewing endothelial cells [4]. The level of growth is correlated to the characteristics of the 
surface and how well they mimic cardiovascular extracellular matrix. Non-adherent surfaces 
prevent endothelial cells from attaching to the endovascular surface, which in turn impedes the 
development of a protective endothelium. A need exists to engineer surfaces for cardiovascular 




Consequently, in order to create a successful cardiovascular scaffold, it is necessary to 
mimic the interaction between the endothelial cell surface receptors with the extracellular matrix 
molecules. This interaction is extremely important in regulating cell adhesion, survival, 
proliferation, migration and differentiation. Once endothelial cells establish adhesive contacts 
with surfaces via integrin-mediated interactions, signaling pathways are activated that initiate 
and direct a diverse amount of cellular activities such as survival, cell-cycle progression, 
vascularization for oxygenation and nutrient delivery and gene expression [5, 6]. Therefore, the 
functionality of endothelial cells is dependent on the success of their adherence to the surface. 
Previous studies have shown enhanced endothelial cell proliferation on surfaces with 
biochemical cues such as growth factors [7] and natural ECM proteins [8], both of which induce 
cell-material interactions.  
Collagen, the main protein in the ECM of blood vessels as well as other tissues in the 
body, has been used extensively to promote cell adhesion [9], specifically for fibroblasts [10], 
human keratinocytes [11], epithelial cells [12], and endothelial cells [13, 14]. Cell adhesion to 
collagen is controlled by two integrins: α1β1 and α2β1 [15]. Fibrillar collagen (collagen type I) 
binds these cellular integrins while exhibiting a triple helical structure, essential to its biological 
and mechanical properties [16]. Integrin α1β1 binds to collagen via MIDAS motif and is the 
only collagen receptor capable of activating Shc mediated growth pathways, indicating a 
distinctive role in cell proliferation on collagen [17]. Integrin α2β1 preferentially binds to a 
triple helical collagen containing the GFOGER motif [18] and regulates the level of matrix 
metalloproteinase-1[19]. Thus, collagen has been incorporated onto biomaterial surfaces to 
promote adhesion via integrin-mediated pathways. For example, collagen has been incorporated 
into nanofiber matrices and has enhanced rat tibia tissue regenerative processes [20], increased 
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human fibroblast activity [21] and increased viability of both smooth muscle cells and 
endothelial cells [22]. Collagen has also been immobilized [23-25] or conjugated onto a variety 
of surfaces [26-28] enabling it to be used in a vast amount of applications.  
Cardiovascular engineered surfaces must not only promote adhesion through cell 
receptors but must also mimic the structure of the natural ECM of the tissue, in turn driving gene 
and protein expression, adhesion, migration, proliferation and differentiation [29]. The 
motivation to use nanostructured surfaces for cardiovascular tissue engineering is driven by this 
fact. Previous studies have shown that nanoscale materials affect cell growth and functionality 
[30-32]. Specifically, nanoscale surfaces improve fibroblast cell adhesion [33], neuronal cell 
differentiation [6], and osteoblast phenotypic activity [34, 35]. Topographical features that 
mimic the natural extracellular matrix have also been shown to encourage endothelial cell 
attachment, proliferation and bioactivity [36]. Nanotopography may result in improved cellular 
adhesion, ultimately leading to enhanced vascularization. Thus, a polymer that is capable of 
being tuned with nanoscale features is required. In this work, we have used polycaprolactone 
(PCL) since it can easily be processed to have nanoscaled features. PCL also has exceptional 
properties for implantation due to the fact that it is bioresorbable polyester with outstanding 
mechanical strength as well as a low degradation rate. Further, its degradation products are 
easily bioresorbed or removed naturally in metabolic pathways such as the citric acid cycle. 
Thus PCL has therefore received a great deal of attention for use as an implantable biomaterial 
and its processability needs to be studies further.  
In this work, we present the immobilization of collagen unto PCL nanowire surfaces. 
PCL nanowire surfaces were fabricated by a solvent-free template synthesis technique 
developed for fabricating controlled arrays of high aspect ratio, substrate-bound nanowires from 
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PCL. This nanotopography was chosen due to the fact that studies have shown it has favorable 
hemocompatible properties [37] and transcellular growth capabilities, specifically neurons [38] 
and mesenchymal stem cells [39]. However, not much is known about how endothelial cells will 
interact to this surface. It is envisioned that the incorporation of collagen unto such 
nanoarchitectures will further act as a framework that may facilitate the synthesis of 
endothelium and promote vascularization. Understanding how to anchor human microvascular 
endothelial cells and the interaction of these cell surface receptors with ECM components will 
provide a foundation for developing functional biomaterials designed to promote human 
microvascular endothelial cell adhesion and growth.  
 
4.2. Materials and methods 
4.2.1. Fabrication and characterization of PCL and NW surfaces. 
Surfaces were fabricated and characterized as described in detail in section 2.2.1 and 2.2.2. 
The nanowire surface architecture was examined for uniformity and repeatability using SEM 
imaging.  
 
4.2.2. Human Microvascular Endothelial Cell (EC) Culture 
ECs (Invitrogen) were suspended in MCDB 131 media enhanced with microvascular 
growth supplement (supplemented with 2 mmol/l glutamine, 100 ug/ml penicillin, and 100 
ug/ml streptomycin) and added to 75 cm2 culture flasks and incubated at 37 ºC under a 5 % CO2 
atmosphere. This study was performed using ECs that were passage 3-6.  
ECs were seeded on PCL, NW, cPCL and cNW surfaces in a 48-well plate. Prior to 
seeding all surfaces were subjected to 30 min UV exposure and conditioned for 5 min in 400 μl 
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of culture medium. ECs cells were seeded at a density of 2 × 104 cells/well. The surfaces were 
incubated at 37 °C under a 5 % CO2 atmosphere in 400 μl of cell rich medium and investigated 
for adhesion, proliferation and viability after 1 and 7 days culture. Further, cellular 
differentiation was investigated after 7 and 14 days of culture. 
 
4.2.3. Adhesion and proliferation of ECs on different surfaces 
Cell adhesion and proliferation was investigated by staining cells with rhodamine 
phalloidin (Cytoskeleton) and 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) 
(Invitrogen) nucleus stain by fluorescence microscope imaging after 1 and 7 days of culture. 
Prior to staining non-adherent cells were removed by aspirating the cell rich medium 
from the surfaces followed by two gentle rinses with PBS. The surfaces were then transferred to 
a new 48-well plate and fixed with 3.7% formaldehyde 15 mins at room temperature. This was 
followed by incubating the surfaces in 1 % Triton-X 100 for 3 mins in order to permeabilize the 
cells. The surfaces were transferred to a new 48-well plate, then incubated in rhodamine-
phalloidin at a concentration of 5 μL/mL for 30 mins. DAPI was added at a concentration of 1 
μL/mL after 25 mins. All the surfaces were rinsed with PBS and imaged with a fluorescence 
microscope (Zeiss). The number of adhered cells on the surfaces was determined using DAPI 
stained images that were analyzed using ImageJ software. 
Cells with evident boundaries adhered onto different surfaces after 1 and 7 days of 
culture were examined using ImageJ software. The cell shape factor was evaluated by the aspect 
ratio of cellular width to cellular length. The cellular width was defined as the diameter of the 
largest circle that would fit entirely within the cell; cellular length was defined by the diameter 
of the smallest circle that encompassed the entire cell.   
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The cell viability was characterized using a commercially available methylthiazol 
tetrazolium (MTT) assay kit (Sigma) after 1 and 7 days of culture. Prior to measuring 
mitochondrial activity, the non-adherent cells were removed by aspirating the cell rich media 
from the surfaces followed by two gentle rinses with PBS. Surfaces were transferred to a new 
48-well plate and incubated in 400 µl of a 10 % MTT solution in PBS for 4 hrs at 37 ºC and 5 % 
CO2. The resulting formazan crystals were dissolved by adding 400 µl of a 10 % SDS solution 
in 0.01 M HCl in PBS to the previous MTT solution. The surfaces were then incubated at 37 ºC 
and 5 % CO2 for 6.5 hrs.  The absorbance of the resulting solution was was measured at a 
wavelength of 690 nm using a plate reader (BMG Labtech). The absorbance is an indirect 
measurement of viability of cells on different surfaces. 
The cell morphology was investigated using SEM imaging to visualize the cellular 
interaction with the surface nanoarchitecture. The non-adherent cells were removed by 
aspirating the cell rich media from the surfaces followed by two gentle rinses with PBS. The 
surfaces were then transferred to a clean petri dish where the cells were fixed and dehydrated. 
The cells were fixed by incubating the surfaces in a solution of primary fixative (3 % 
glutaraldehyde (Sigma), 0.1 M sodium cacodylate (Polysciences), and 0.1 M sucrose (Sigma)) 
for 45 min. They were then incubated in a solution of secondary fixative (primary fixative 
without gluteraldehyde) for 10 min. Subsequently, the surfaces were dehydrated by incubation 
in consecutive solutions of increasing ethanol concentrations (35 %, 50 %, 70 %, 95 %, and 100 
%) for 10 min each. Further dehydration of the cells was accomplished by incubating the 
surfaces in hexamethyldisilazane (HMDS, Sigma) for 10 min. They were then air dried and 
stored in a desiccator until further imaging by SEM. The surfaces were coated with a 10 nm 
layer of gold and imaged at 5-7 kV. 
!
! 96 
4.2.4. Differentiation of ECs on different surfaces 
After 7 and 14 days of culture, indirect immunofluorescence staining was used to 
determine cellular expression and differentiation through the presence of membrane specific 
marker proteins on ECs. The ECs were immunostained for the presence of the endogenous 
proteins, von Willebrand factor (vWF) and vascular endothelial cadherin (VE-cadherin). 
Further, a western blot analysis was used to quantify the expression of these proteins on 
different surfaces. 
The non-adherent cells were removed by aspirating the cell rich media from the 
surfaces followed by two gentle rinses with PBS. The surfaces were then transferred to a new 
48-well plate. Adherent cells were fixed in 3.7 % w/v formaldehyde in PBS for 15 min at room 
temperature and washed three times in PBS. The cell membrane was permeabilized by 
incubating the surfaces in a 1 % Triton-X solution in PBS at room temperature for 3 mins, 
followed by gentle rinse with PBS. To block nonspecific binding, the surfaces were incubated in 
10 % blocking serum in PBS for 30 mins at room temperature. The surfaces were then incubated 
in a primary antibody solution (mouse monoclonal, rabbit polyclonal) (dilution 1:50, Santa Cruz 
Biotechnology) with 2 % blocking serum in PBS for 1 hr at room temperature.  The surfaces 
were then washed three times (5 mins per wash) in PBS, and incubated with an appropriate 
fluorescently labeled secondary antibody solution (chicken anti-mouse-HRP, goat anti-rabbit-
HRP) (dilution 1:100, Santa Cruz Biotechnology) with 2 % blocking serum in PBS for 1 hr at 
room temperature. The surfaces were washed three times (5 mins per wash) in PBS, and imaged 
with a fluorescence microscope. 
Western blotting was performed to identify endothelial cell–specific proteins, vWF, and 
VE-cadherin expression in ECs. Briefly, cells on surfaces after 7 and 14 days in culture were 
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homogenized in RIPA lysis buffer (10.0 mM Tris pH 7.4, 100.0 mM NaCl, 5.0 mM EDTA, 5.0 
mM EGTA, 1.0% Deoxycholate, 0.1% SDS, 1.0% Triton X-100) containing protease inhibitor 
cocktail. The lysate protein content was determined by micro-BCA assay. The lysate was heated 
to 65 °C for 20 mins in sample buffer (62.5 mM Tris-HCl pH 6.8, 10.0 % glycerol, 5.0 % β-
mercaptoethanol, 2.0% SDS, 0.025 % Bromophenol blue) in order to denature the proteins prior 
to gel loading. 20 µg of total extract protein was electrophoresed through 8 % Tris-SDS gels and 
transferred to PVDF membranes in 7.5% methanol. Blots were blocked for 1 hr at room 
temperature. Primary monoclonal antibodies for vWF and VE-cadherin were diluted 1:500 in 
3% BSA in PBS-tween solution and incubated overnight at 4 °C. The blots were then washed 
three times with PBS-tween solution (5 mins per wash) before they were incubated with goat 
anti-mouse or donkey anti-rabbit horseradish peroxidase (HRP) conjugated secondary antibodies 
(Santa Cruz Biotechnology) at a dilution of 1:5000 for 1 hr at room temperature. The blots were 
then washed three times with PBS-tween solution (5 mins per wash) followed by protein 
detection using chemiluminescence (WestPico Chemiluminescent Substrate; Pierce).  The blots 
were imaged using an Alpha Innotech Fluorchem gel documentation system, and band 
intensities were analyzed using ImageJ software.  
 
4.2.5. Statistics 
Each experiment was confirmed on three different surfaces with at least three different 
cell populations (nmin = 9). All the quantitative results were analyzed using ANOVA and 





4.3. Results and Discussion 
Understanding how to anchor ECs and the interaction of the cell surface receptors with 
the ECM components will provide a foundation for developing functional biomaterials designed 
to promote EC adhesion and growth. ECs must be capable of withstanding blood flow and their 
viability is essential for cardiovascular health. It has been shown that endothelial cells exhibit 
enhanced adherence to collagen, while maintaining their in vivo phenotype on nanostructured 
surfaces. Therefore, the interaction of ECs with collagen immobilized PCL nanowire surfaces 
was investigated in this study.  
 
4.3.1. Characterization of different surfaces 
Surfaces were fabricated and characterized as described in detail in section 2.2.1 and 
2.2.2. The nanowire surface architecture was examined for uniformity and repeatability using 
SEM imaging  (Figure 4.1.). 
 
4.3.2. Adhesion and proliferation of ECs on different surfaces 
EC adhesion and proliferation was evaluated after 1 and 7 days of culture by staining 
adhered cells with rhodamine-phalloidin, a cytoskeleton stain, and DAPI, a nuclei stain and 
imaging the surfaces using fluorescence microscope (Figure 4.2.). At day 1 it is evident that 
cells adhered unto NW, cPCL and cNW surfaces have an elongated phenotype compared to PCL 
surfaces. Furthermore, after 7 days of culture there are more cells covering and interacting on 
both cPCL and cNW surfaces compared to plain PCL and NW surfaces.  
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Figure 4.1. Representative scanning electron microscopy images of PCL and NW surfaces after 
each step of immobilization process (unmodified, + NH2, + Collagen). 
 
100 
Figure 4.2. Representative fluorescence microscopy images of ECs stained with Rhodamine 
Phalloidin (red) and DAPI (blue) on PCL, NW, cPCL and cNW surfaces. Experiments were 
replicated on at least three different samples with at least three different cell populations (nmin = 
9). 
EC adhesion was quantified by counting the number of DAPI stained nuclei on each 
fluorescent image. The results indicate that the cell adhesion of ECs on day 1 and 7 is 
significantly higher on NW, cPCL and cNW surfaces compared to PCL surfaces (Figure 
4.3.(a)). This may be due to the enhanced surface energy of these surfaces compared to PCL. 
Higher surface energies are known to increase the adhesion of cells. Further, collagen has been 
known to increase cellular anchorage to substrates via the ß1 integrin family of extracellular 
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matrix receptors [26, 40]. Cellular adhesion plays a large role in cellular communication and 
regulation, indicating that collagen immobilized surfaces may serve as an excellent substrate for 
the anchorage dependent endothelial cells. By introducing nanoarchitecture as well as a cell 
binding motif it is apparent that more cells are adhering, indicating that mimicking the natural-
like hierarchy of tissue and providing ECM components are important in anchoring ECs.  
 
 
Figure 4.3. (a) Cell counts on different surfaces after 1 and 7 days of culture. Cell nuclei stained 
with DAPI were quantified using ImageJ software. After 1 and 7 days of culture, there were 
statistically less number of cells adhered on PCL surfaces as compared to NW, cPCL and cNW 
(p < 0.05). (b) Shape factor approximations of cells on different surfaces after 1 and 7 days of 
culture. After 1 day of culture, ECs on NW surfaces had a significantly lower shape factor (more 
elongated body) than those on PCL surfaces (p < 0.05). After 7 days of culture, ECs on cNW 





Cell viability measured using the MTT assay for ECs on different surfaces. PCL, NW, cPCL and 
cNW surfaces had a significant increase in EC mitochondrial activity from day 1 to day 7.  After 
1 day of culture, cell viability was significantly increased on cNW surfaces compared to PCL 
and NW surfaces (p < 0.05). After 7 days of culture, cell viability was significantly increased on 
cPCL and cNW surfaces compared to both PCL and NW surfaces (p < 0.05). Error bars 
represent standard deviation. Experiments were replicated on at least three different samples 
with at least three different cell populations (nmin = 9). Error bars represent standard deviation. 
 
Further, as evident from the fluorescence microscope images (Figure 4.2.), the cells 
exhibit different morphologies on different surfaces. Thus, cell shape factor was evaluated on 
each surface by determining the aspect ratio of cellular width to cellular length (Figure 4.3.(b)). 
A low cell shape factor indicates an elongated cell body and high cell shape factor indicated a 
spherical cell body. Cell shape factor calculations show that cells on nanostructured surfaces are 
more elongated than on surfaces without nanoarchitecture. After 1 day of culture, cells on NW 
surfaces had a significantly lower shape factor (more elongated body) than cells on PCL 
surfaces. After 7 days of culture, cells on cNW surfaces had significantly lower shape factors 
than cells on PCL, NW and cPCL surfaces. The significant elongation of ECs on cNW surfaces 
may be due to the increased anchorage of these cells. Vascular endothelial cells appear to be 
aligned with the flow in the immediate vicinity of the vascular wall and have a shape which is 
more ellipsoidal in regions of high shear and more polygonal in regions of low shear stress [41]. 
This shape is induced with nanotopography that may be important to maintaining the natural 




The viability of cells on different surfaces was determined using a commercially 
available MTT assay. This colorimetric assay measures cellular metabolic activity via 
NAD(P)H-dependent cellular oxidoreductase enzymes. Cellular enzymes reduce tetrazolium dye 
into its insoluble formazan form, giving it a purple color. This colored solution can be quantified 
by measuring absorbance at 690 nm with a spectrophotometer. The results indicate that the cell 
viability increases on all surfaces after 7 days of culture, however the cell viability was 
significantly greater on cPCL and cNW surfaces compared to PCL and NW surfaces (Figure 
4.3.(c)). These results are consistent with cell adhesion results (Figure 4.3.(a)). More cells 
adhering unto surfaces leads to an increase in cell-cell contact and cellular alignment on cPCL 




Figure 4.4. Representative SEM images of ECs after 1 and 7 days of culture on different 
surfaces. Note: the surfaces were coated with a 10 nm layer of gold and imaged at 7 keV. 
Experiments were replicated on at least three different samples with at least three different cell 
populations (nmin = 9). 
The cell morphology was investigated using SEM imaging to visualize the cellular 
interaction with the surface nanoarchitecture. The nanoscale surface topography of materials is 
known to play a significant role in interactions with biological systems such as proteins and cells 
[42]. Results indicate that cells interact with NW and cNW by forming filopodia that network 
with the nanoscale features present (Figure 4.4.). It is evident that on day 7, ECs on NW and 
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cNW surfaces are depositing more extracellular matrix proteins on the surface compared to PCL, 
and cPCL surfaces, with cNW surfaces depositing the most. The nanoscale topography present 
on both NW and cNW surfaces contribute to the deposition of more extracellular proteins. It has 
also been shown that endothelial cells exhibit more of their natural phenotype in vitro on 
nanostructured surfaces versus in flat culture dishes [43]. Furthermore, ECs on cPCL surfaces 
form cell-cell junctions as evident from the filopodia extending between cells present both on 
day 1 and day 7. ECs do not seem to interact as well with PCL surfaces when compared to NW, 
cPCL and cNW surfaces as evident by the lack of filopodia and ECM deposition. This may be 
due to the lack of nano-architecture and cell binding motifs.  
 
4.3.3. Differentiation of ECs on different surfaces 
Differentiation of cells on surfaces was investigated by detecting vWF and VE-cadherin 
expression both through immunofluorescence and western blotting techniques. vWF and VE-
cadherin are specific to endothelial cells and are expressed only when endothelial cells 
differentiate into mature phenotype. vWF is a large glycoprotein synthesized by vascular 
endothelial cells but is also found in plasma and platelets. It plays a role in the coagulation of 
blood at injury sites. VE-cadherin mediates cell-cell binding critical to tissue structure and 
morphogenesis. VE-cadherin is the major determinant of endothelial cell contact integrity and 
regulation of its activity or its presence at cell contacts is an essential step that controls the 
permeability of the blood vessel wall for cells and substances [44]. Immunofluorescence images 
indicate no clear differences in vWF expression on different surfaces (Figure 4.5.(a)). 
Clustering of vWF is seen on the collagen immobilized surfaces. vWF is known to bind to 
collagen which may be why clustering is occurring [45]. Further, immunofluorescence images 
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indicate an increase in VE-cadherin expression on NW, cPCL and cNW surfaces compared to 
PCL surfaces (Figure 4.5.(b)).  
In order to quantify vWF and VE-cadherin protein expression, a western blotting 
technique was used. Results indicate that after 7 days of culture, vWF expression is statistically 
higher on NW surfaces (Figure 4.6.(a)). However, after 14 days in culture, vWF expression is 
statistically similar on all surfaces. Further, there is no significant increase in vWF expression 
from day 7 to day 14 on any of the surfaces. vWF expression is extremely important in 
endothelial cells. Platelets adhere to vWF, initiating the blood clotting cascade when injury 
occurs. Thus, endothelial cells must be capable of vWF expression, however an increase in vWF 





Figure 4.5. Representative fluorescence microscopy images of ECs immunostained with (a) 
vWF and (b) VE-cadherin. Experiments were replicated on at least three different samples with 




Figure 4.6. Western blot analysis of the expression of (a) vWF and (b) VE-Cadherin on 
different surfaces after 7 and 14 days in culture normalized to (c) "-tubulin. After 7 days of 
culture vWF expression is statistically higher on NW surfaces. After 14 days in culture, vWF 
expression is statistically similar on all surfaces. After 7 in culture, VE-cadherin expression is 
similar on all surfaces. After 14 days in culture, VE-cadherin expression is significantly higher 
on nanostructured surfaces (NW and cNW) compared to PCL and cPCL surfaces. There is also a 
significant increase in VE-cadherin expression from day 7 to 14 on NW and cNW surfaces. 
Experiments were replicated with western blots with at least three different cell populations  
After 7 in culture, VE-cadherin expression is similar on all surfaces (Figure 4.6.(b)). 
However, after 14 days in culture, VE-cadherin expression is significantly higher on 
nanostructured surfaces (NW and cNW) compared to PCL and cPCL surfaces. There is also a 









































































cadherin expression is important in cellular contacts, which will eventually regulate the 
permeability of the blood vessel, therefore an increase in VE-cadherin expression is necessary 
for healthy vasculature. Increased expression can be seen on surfaces with nanostructured 
features (NW and cNW). 
 
4.4. Conclusion 
A thorough understanding of the interaction between ECs and the biomaterial surface is 
essential in order to promote healing and regeneration through integration with native tissue. 
One major obstacle to overcome is adhesion of the anchorage-dependent and slowly renewing 
ECs on material surfaces. The level of cell growth is correlated to the characteristics of the 
material surface and its ability to mimic properties similar to extracellular matrix. Therefore, 
providing ECs with nanotopography and cell-binding motifs such as collagen may affect the cell 
adhesion, viability, morphology and differentiation. In this study, ECs exhibited increased 
adhesion and viability on NW, cPCL and cNW surfaces. ECs have a more elongated body and 
low shape factor on nanostructured surfaces (NW and cNW) compared to smooth surfaces (PCL 
and cPCL). The differentiation potential of collagen immobilized nanowire surfaces was also 
evaluated by immunostaining and western blotting for key endothelial cell markers, vWF and 
VE-cadherin. The expression of VE-cadherin is increased on nanostructured surfaces after 14 
days in cuture, indicating more cell-cell contacts. The expression of vWF is statistically similar 
on all surfaces after 14 days in culture with no significant increase from 7 to 14 days in culture, 
indicating that increased perturbation of the endothelial layer on any surface is not occurring. 
The results presented here indicate that ECs adhesion and differentiation can be modulated by 
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The vascular smooth muscle cell’s (SMC) main function is contraction and adjustment of 
blood vessel diameter, blood pressure, and blood flow distribution [1]. SMCs have the capacity 
for contraction, migration, proliferation, synthesis of extracellular matrix (ECM) components 
and the secretion of growth factors and cytokines [2]. This allows SMCs to regulate lumen 
diameter both transiently and chronically [3]. SMCs are key players in the development of 
vascular disease due to their plasticity or ability to change phenotype and behavior according to 
varying environmental conditions [4]. The standard treatment for vascular disease is coronary 
angioplasty, which leads to disorder of the endothelial layer. This leaves a highly prothrombotic 
surface exposed to the blood stream and promotes SMC dedifferentiation followed by 
proliferation [5, 6]. Restoration of an endothelium represents a crucial process in re-establishing 
an intact vessel surface, but in order to do this SMC proliferation must be controlled. Enhanced 
SMC proliferation often leads to restenosis, the reocclusion of the blood vessel. This can be 
caused by SMC migration, proliferation and neointimal thickening and further limits the success 
of balloon angioplasty and stent implantation [7]. 
SMCs exhibit two well-known phenotypes; contractile and synthetic [8]. Contractile 
SMCs are elongated and spindle shaped, whereas synthetic SMCs are less elongated and have an 
epithelioid morphology. Synthetic SMCs contain organelles involved in protein synthesis, 
whereas in contractile SMCs, these organelles are replaced with contractile filaments. Further, 
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synthetic and contractile SMCs exhibit different proliferation rates. Synthetic SMCs proliferate 
at higher rates compared to contractile SMCs. Contractile SMCs in adult blood vessels 
proliferate at an exceptionally low rate, demonstrate low synthetic activity, and express a unique 
selection of contractile proteins and signaling molecules required for contractile function [9]. 
SMCs within adult blood vessels are incredibly plastic and can easily change phenotype, a 
process also known as phenotypic switching. This occurs in response to vascular injury, allowing 
them to proliferate at high rates [10, 11]. SMC phenotypic switching is characterized by a 
decrease in the expression of SMC specific differentiation proteins and increased SMC 
proliferation, migration, and synthesis of ECM components required for repair of vasculature. 
An unfortunate consequence of SMC plasticity is that environmental cues and signals can 
promote SMC phenotypic switching and stimulate the development and/or progression of 
vascular disease [2]. There is evidence that phenotypic switching of SMCs plays a significant 
role in a repertoire of diseases in humans, such as atherosclerosis, asthma, hypertension, and 
cancer [4]. A decrease in proliferation, however, is not sufficient to promote SMC differentiation 
[2].  
Biomaterial–cell interactions are fundamental in various biological events and determine 
the longevity and functionality of implanted devices. It is well known that cardiovascular 
biomaterial implants, such as stents, perturb the endothelium layer, promoting SMC migration 
and proliferation, ultimately leading to restenosis and failure of the implant [12]. However, this 
may be avoidable with the design of a biomaterial surface capable of influencing cellular 
interactions. Enhancement of cell-biomaterial interactions can be altered by immobilizing 
surfaces with extracellular matrix (ECM) molecules such as fibronectin, laminin, collagen, or 
vitronectin [13]. By modifying biomaterial surfaces with these ECM components, cell-binding 
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sites are introduced which may promote cell functionality.  One such ECM molecule is collagen 
1. It is the main component in the ECM of blood vessels as well as other tissues in the body, and 
has been used extensively to promote smooth muscle cell adhesion on biomaterial surfaces [14, 
15]. Further, it is also known to promote the contractile phenotype in SMCs [16]. Another 
popular approach for controlling cell functionality on implant surfaces is the introduction of 
surface topographies at a nanometer or micrometer scale. Due to the existence of functional 
nanoscale structures within native tissue, nanostructured surfaces have attracted attention. 
Nanoscale features can influence cellular responses ranging from initial attachment and 
migration to differentiation and synthesis of new ECM. Studies have shown that proliferation of 
the SMCs is significantly reduced on the nanopatterned surfaces, while these surfaces also 
promote the alignment of cells [17, 18]. Topographical features that mimic the natural 
extracellular matrix have also been shown to encourage SMC attachment and bioactivity, [19, 
20] while limiting proliferation [21]. 
In this study, we have used polycaprolactone since it has exceptional properties for 
implantation such as outstanding mechanical strength and a low degradation rate in physiological 
conditions.  It can also easily be processed to have nanoscaled features. Further, its degradation 
products are easily bioresorbed or removed naturally in metabolic pathways such as the citric 
acid cycle. Polycaprolactone has therefore received a great deal of attention for use as an 
implantable biomaterial for many tissue engineering applications including cardiovascular 
applications [22-24].  
In this work, we present the immobilization of collagen I unto polycaprolactone nanowire 
surfaces. Polycaprolactone nanowire surfaces were fabricated by a solvent-free template 
synthesis technique developed for fabricating controlled arrays of high aspect ratio, substrate-
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bound nanowires from polycaprolactone. This nanotopography was chosen since it has shown 
promising hemocompatible properties [25] and transcellular growth capabilities, specifically 
neurons [26] and mesenchymal stem cells [27]. However, not much is known about how SMCs 
will interact with this surface. It is envisioned that the incorporation of collagen on nanowires 
may facilitate the adherence and differentiation of SMCs. The objective of this work is to 
investigate how SMCs interact with nanowire topography to see if these surfaces have potential 
for cardiovascular implants. Understanding how to anchor smooth muscle cells and the 
interaction of the cell surface receptors with the ECM components will provide a foundation for 
developing functional vascular biomaterials that inhibit unwarranted vascular SMC proliferation 
and preserve a differentiated state of SMCs to manage and avoid vascular disease conditions. 
 
5.2. Materials and Methods  
5.2.1. Fabrication of PCL nanowire surfaces 
Surfaces were fabricated and characterized as described in detail in section 2.2.1 and 
2.2.2. The nanowire surface architecture was examined for uniformity and repeatability using 
SEM imaging.  
 
5.2.2. Smooth Muscle Cell Culture 
Human Aortic SMCs (Life Technologies) were suspended in MCDB 131 media (Life 
Technologies) enhanced with SMC growth supplement (supplemented with 2 mmol/l glutamine, 
100 ug/ml penicillin, and 100 ug/ml streptomycin) and added to 75 cm2 culture flasks and 
incubated at standard culture conditions. This study was performed using SMCs that were 
passage 4.  
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SMCs were cultured on PCL, NW, cPCL and cNW surfaces in a 48-well plate. Prior to 
seeding, all surfaces were subjected to 30 min UV exposure and conditioned for 5 min in 400 μl 
of culture medium. SMCs cells were seeded at a density of 2 × 104 cells/well. The surfaces were 
incubated in standard culture conditions in 400 μl of cell rich medium and investigated for 
adhesion, proliferation and viability after 1 and 7 days culture. After 7 days in culture, media 
changes were done with MCDB 131 media enhanced with with SMC differentiation supplement 
(supplemented with 2 mmol/l glutamine, 100 ug/ml penicillin, and 100 ug/ml streptomycin). 
SMC differentiation was investigated after 14 and 21 days of culture.  
 
5.2.3. Adhesion and proliferation of SMCs on different surfaces 
Cellular adhesion and proliferation was investigated using 5-Chloromethylfluorescein 
Diacetate (CMFDA) live cytoplasm stain (Invitrogen), Rhodamine Phalloidin F-actin 
cytoskeleton stain (Cytoskeleton) and 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) 
nucleus stain (Invitrogen) by fluorescence microscope imaging after 1 and 7 days of culture. 
Prior to staining nonadherent cells were removed by aspirating the medium from the 
surfaces followed by two gentle rinses with PBS. The surfaces were then transferred to a new 48-
well plate and incubated with 10 μM CMFDA solution in PBS for 30 min at 37 °C and 5 % CO2 
followed by another incubation in PBS for another 30 min at 37 °C and 5 % CO2. 3.7 % 
formaldehyde was then added to fix the cells for 15 min at room temperature. This was followed 
by 2 gentle rinses in PBS prior to incubating the surfaces in 1 % Triton-X 100 for 3 min in order 
to permeabilize the cells. The surfaces were rinsed in PBS (3x 5 min), and then incubated in 5 
μL/mL rhodamine-phalloidin solution for 30 min. After 25 min 1 μL/mL DAPI was added to the 
rhodamine-phalloidin solution. All the surfaces were rinsed and stored in PBS until imaged using 
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a Zeiss Axioplan 2 fluorescence microscope. The number of cells adherent on the surfaces was 
determined from the number of stained nuclei in the DAPI fluorescence images using ImageJ 
software. 
 
5.2.4. SMC elongation on different surfaces 
SMCs adhered onto cPCL and cNW surfaces after 1 and 7 days of culture with evident 
boundaries were examined using ImageJ software to acquire an approximation for cellular 
elongation. Cellular elongation was calculated as the aspect ratio of cellular length to cellular 
width, outputting an elongation [E] parameter [28]. Cellular length was defined by the diameter 
of the smallest circle that encompassed the entire cell, while cellular width was defined as the 
diameter of the largest circle that would fit entirely within the cell. E provides a description for 
the extent of equimomental elipse lengthening. Thus, E is zero for a circle, and one for an ellipse 
with an axis ratio of 1:2.  
 
5.2.5. Viability of SMCs on different surfaces 
The cell viability was characterized using a commercially available Methylthiazol 
Tetrazolium (MTT) assay kit (Sigma) on days 1 and 7 in culture. Prior to measuring 
mitochondrial activity, the unadhered SMCs were removed by aspirating the cell rich media from 
the surfaces followed by two gentle rinses with PBS. Surfaces were transferred to a new 24-well 
plate and incubated in 10 % MTT solution in PBS for 3.5 hrs at 37 ºC and 5 % CO2. The 
subsequent formazan crystals were dissolved by adding a 10 % Triton-X in MTT solvent mixture 
in equal amounts to the MTT solution in PBS. The absorbance of the solution was measured at a 
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wavelength of 690 nm using a plate reader (BMG Labtech). The mitochondric activity of the 
cells on different surfaces correlate to the resulting absorbance values. 
 
5.2.6. Morphology of SMCs on different surfaces  
SMC morphology was investigated using SEM imaging to visualize the cellular 
interaction with the nano-architecture. The un-adhered cells were removed by aspirating media 
from the surfaces followed by two gentle rinses with PBS. The surfaces were then transferred to 
a clean petri-dish where the cells were fixed and dehydrated on the surface. The cells were fixed 
by incubating the surfaces in a solution of primary fixative (3 % glutaraldehyde (Sigma), 0.1 M 
sodium cacodylate (Polysciences), and 0.1 M sucrose (Sigma)) for 45 min. Surfaces were then 
incubated in a solution of secondary fixative (primary fixative without gluteraldehyde) for 10 
min. Next, the surfaces were dehydrated by incubation in consecutive solutions of increasing 
ethanol concentrations (35 %, 50 %, 70 %, 95 %, and 100 %) for 10 min each. Further 
dehydration of the cells was accomplished by incubating the surfaces in hexamethyldisilazane 
(HMDS, Sigma) for 10 min. Surfaces were then air dried and stored in a desiccator until imaging 
by SEM. The surfaces were coated with a 10 nm layer of gold and imaged at 5-7 kV. 
 
5.2.7. Differentiation of SMCs on different surfaces 
The SMCs on different surfaces were studied for the expression of heavy chain myosin 
(MYH) and calponin (CAL). MYH expression has never been detected in non-SMCs and is the 
only marker protein that is also SMC specific during embryogenesis. CAL is a thin filament 
protein involved in the regulation of actin-myosin interactions in SMCs.  
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First, western blotting was performed to identify SMC specific proteins, MYH and CAL, 
and semi-quantify their expression. Briefly, cells on surfaces after 7, 14 and 21 days in culture 
were homogenized in RIPA lysis buffer (10.0 mM Tris pH 7.4, 100.0 mM NaCl, 5.0 mM EDTA, 
5.0 mM EGTA, 1.0% Deoxycholate, 0.1% SDS, 1.0% Triton X-100) containing protease 
inhibitor cocktail. The lysate protein content was determined by micro-BCA assay. The lysate 
was heated to 95 °C for 20 min in sample buffer (62.5 mM Tris-HCl pH 6.8, 10.0 % glycerol, 5.0 
% β-mercaptoethanol, 2.0 % SDS, 0.025 % Bromophenol blue) in order to denature the proteins 
prior to gel loading. An equivalent amount of total extract protein was electrophoresed through 8 
% Tris-SDS gels and transferred to PVDF membranes in 7.5 % methanol. Blots were blocked for 
1 hr at room temperature. Primary monoclonal antibodies for MYH and CAL were diluted 1:200 
in 3% BSA in PBS-tween solution and incubated overnight at 4 °C. The blots were then washed 
with PBS-tween solution (3x 5 min) before they were incubated with goat anti-mouse or donkey 
anti-rabbit horseradish peroxidase (HRP) conjugated secondary antibodies (Santa Cruz 
Biotechnology) at a dilution of 1:5000 for 1 hr at room temperature. The blots were then washed 
with PBS-tween solution (3x 5 min) followed by protein detection using chemiluminescence 
(WestPico Chemiluminescent Substrate; Pierce).  The blots were imaged using an Alpha 
Innotech Fluorchem gel documentation system, and band intensities were analyzed using ImageJ 
software. 
After 21 days of culture, indirect immunofluorescence staining was used to determine 
cellular phenotype through the presence of endogenous proteins specific to SMCs when in a 
mature state. The un-adhered SMCs were removed by aspirating the cell rich media from the 
surfaces followed by two gentle rinses with PBS. The surfaces were then transferred to a new 48-
well plate. Adherent cells were fixed in 3.7 wt% formaldehyde in PBS for 15 min at room 
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temperature and washed in PBS (3x 5 min). The cell membranes were permeabilized using 1 % 
Triton-X in PBS at room temperature for 3 min, and washed in PBS (3x 5 min). Subsequently, 
surfaces were incubated in 10 % BSA in PBS for 30 min at room temperature. A primary 
antibody (dilution 1:50, Santa Cruz Biotechnology) with 2 % blocking serum in PBS was 
administered for 1 hr at room temperature.  
Surfaces were then washed in PBS (3x 5 min), and incubated with an appropriate 
secondary fluorescently labeled antibody (dilution 1:100, Santa Cruz Biotechnology, Santa Cruz, 
CA) with 2 % blocking serum in PBS for 1 hr at room temperature. The surfaces were washed in 
PBS (3x 5 min) and imaged with a fluorescent microscope. All images were processed using 




Each experiment was confirmed on three different substrates with at least three different 
cell populations (nmin = 9). All the quantitative results were analyzed using ANOVA and a 
Tukey’s post hoc test. Statistical significance was considered at p < 0.05. 
 
5.3. Results and Discussion 
Understanding how SMCs respond to biomaterial surfaces as well as how cell surface 
receptors interact with the ECM components will provide a foundation for developing functional 
biomaterials designed to promote a contractile SMC phenotype. In general SMC phenotypic 
switching is characterized by markedly reduced expression of SMC-selective differentiation 
marker genes and increased SMC proliferation, migration, and synthesis of extra- cellular matrix 
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components required for vascular repair. This can often lead to restenosis and can progress the 
development of vascular disease. In this study, we explore the effect that the combination of both 
surface nanoarchitecture and cell binding motifs on SMC adhesion, viability, proliferation and 
differentiation. 
 
5.3.1. Characterization of Surfaces 
The surface architecture of the different surfaces before and after the collagen 
immobilization process was characterized using SEM. Results reveal that surface architecture 
remains consistent before and after collagen immobilization (Figure 5.1.).  
 




5.3.2. Adhesion and Proliferation of SMCs 
SMC adhesion and proliferation was evaluated after 1 and 7 days of culture by using 5-
Chloromethylfluorescein Diacetate (CMFDA) live stain (Invitrogen), Rhodamine Phalloidin 
(Cytoskeleton) and 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) (Invitrogen) nucleus 
stain, followed by imaging with a fluorescence microscope (Figure 5.2.). At day 1, it is evident 
that cells adhered on NW, cPCL and cNW surfaces have an elongated phenotype compared to 
PCL surfaces. SMCs on NW, cPCL and cNW also exhibit multiple cellular extensions 
interacting with the surfaces as well as with surrounding cells. After 7 days of culture there are 
more cells covering and interacting on both cPCL and cNW surfaces as compared to PCL and 
NW surfaces. It is important to note that the cells on the nanostructured surfaces (NW and cNW) 
seem to be aligning and more spindle-shaped compared to the flat surfaces (PCL and cPCL). 
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Figure 5.2. Representative fluorescence microscopy images of SMCs stained with CMFDA 
(green), Rhodamine Phalloidin (red) and DAPI (blue) on PCL, NW, cPCL and cNW surfaces. 
Experiments were replicated on at least three different samples with at least three different cell 
populations (nmin = 9). 
SMC adhesion was quantified by counting the number of DAPI stained nuclei on 
fluorescence microscopy images using ImageJ software. The results indicate that after 1 day in 
culture SMC adhesion on PCL surfaces is statistically similar to that on cPCL surfaces, however 
adhesion on PCL surfaces is significantly lower than that on NW and cNW surfaces (Figure 
5.3.). After 7 days of culture, NW, cPCL and cNW surfaces exhibit higher cellular adhesion as 
























surfaces from day 1 to 7. This may be due to the enhanced energy of these surfaces compared to 
PCL surface. Higher surface energy is known to promote cell adhesion. Further, collagen 
immobilized unto these surfaces presents more cell binding motifs for cells to adhere to. In 
natural tissue cells are surrounded with ECM, therefore cells will interact with a biomaterial in a 
comparable way if it contains similar binding sites to that of the natural ECM [29]. Collagen has 
been known to increase cellular anchorage to substrates via the ß1 integrin family of extracellular 
matrix receptors [30, 31]. Cellular adhesion plays a large role in cellular communication and 
regulation, indicating that collagen immobilized surfaces may serve as an excellent substrate for 
the adhesion of SMCs. The nanostructured and collagen immobilized surfaces promote initial 
cellular adhesion, and hence there are more cells on these surfaces. By introducing 
nanoarchitecture as well as a cell binding motif it is apparent that more cells are adhering, 
indicating that mimicking the natural-like hierarchy of tissue and providing ECM components 
are important in anchoring SMCs.  
 
Figure 5.3. Cell counts on different surfaces after 1and 7 days of culture. Cell nuclei stained 
with DAPI were quantified using ImageJ software. Experiments were replicated on at least three 



















was calculated using a one-way ANOVA with Tukey’s post hoc test. After 1 day in culture, the 
cellular adhesion of SMCs on PCL surfaces is significantly lower than the adhesion on NW and 
cNW surfaces, whereas there is no significant difference between cellular adhesion on cPCL, 
NW and cNW surfaces. After 7 days in culture, the cPCL, NW and cNW surfaces exhibit 
significantly higher cellular adhesion than PCL surfaces, whereas, there is no significant 
difference between cellular adhesion on the cPCL, NW and cNW surfaces. Error bars represent 
the standard error. 
 
5.3.2. SMC elongation on different surfaces 
SMCs adhered onto different surfaces after 1 and 7 days of culture with evident 
boundaries were examined using ImageJ software to acquire an approximation for cellular 
elongation. Cellular elongation was calculated as the aspect ratio of cellular length to cellular 
width, outputting an elongation [E] parameter. Results indicate that cNW surfaces exhibit a more 
elongated morphology after 1 and 7 days of culture compared to PCL surfaces at the same time 
points Figure 5.4(A). SMCs also exhibited significantly more elongation on cNW surfaces after 
7 days of culture as compared to those after 1 day of culture. Contractile SMCs are more 
elongated and spindle-shaped cells, whereas synthetic SMCs have a cobblestone morphology 
also known as epithelioid. Thus a higher E value is associated with a contractile phenotype. The 
large error in average E value is attributed to the vast distribution of cellular elongation on the 
surfaces. Therefore, a histogram of cellular E values on the different surfaces was constructed in 
order to see the distribution of cellular shapes Figure 5.4.(C, D). After 1 day in culture, the 
histogram indicates that the majority of cells on PCL surfaces have an E value between 1 and 2. 
SMCs on NW and cPCL surfaces have a large distribution of cell shapes with peaks being 
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between E values of 3 and 4. Cells on cNW surfaces, which contain both nanoarchitecture as 
well as cell binding motifs, have the largest number of elongated cells (E values greater than 10). 
Further, after 7 days of culture NW and cNW surfaces are the only surfaces which adhere SMCs 
with an E value greater than 20. 
 
Figure 5.4. (A) Elongation (E) approximations of cells on different surfaces after 1 and 7 
days of culture. Experiments were replicated on at least three different samples with at 
least three different cell populations (nmin = 9). Statistical significance was calculated using 
a one-way ANOVA with Tukey’s post hoc test. Results indicate that colNW surfaces 
exhibit a more elongated morphology after 1 and 7 days of culture compared to PCL 
surfaces at the same time points (*, #, p < 0.05). SMCs also become significantly more 
elongated on cNW surfaces after 7 days of culture compared to those in culture for 1 day 
on cNW surfaces (¢, p < 0.05). Error bars represent the standard error; (B) The image 
shows how E approximations were calculated (outer diameter/inner diameter); A histogram 
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of E approximations of cells on different surfaces after (C) 1 day in culture and (D) 7 days 
in culture. 
 
5.3.3. Viability of SMCs on surfaces 
The cell viability was characterized using a commercially available Methylthiazol 
Tetrazolium (MTT) assay kit (Sigma) after days 1 and 7 in culture. This assay is dependent on 
NAD(P)H-dependent oxidoreductase enzymes located in the cytosolic compartment of cells, 
which reduce the tetrazolium dye [32, 33]. Therefore, this assay can be used to measure the loss 
of viable cells or the cytostatic activity of cells. Results indicate after 1 day in culture SMCs on 
cNW surfaces have significantly lower MTT reduction rates than PCL, NW and cPCL surfaces 
(Figure 5.5.). After 7 days in culture, SMCs have significantly higher MTT reduction rates on 
cPCL>(PCL>NW>cNW). Studies have shown that proliferation of smooth muscle cells is 
significantly reduced on nanopatterned surfaces [21]. Rapidly dividing cells demonstrate high 
rates of MTT reduction, while differentiated cells exhibit low rates of MTT reduction. This can 
be seen in the lower values of MTT reduction of SMCs on NW and cNW surfaces compared to 
both PCL and cPCL surfaces. Despite significantly higher number of cells on cNW surfaces after 
day 7 of culture as compared to PCL, NW and cPCL surfaces, the cells on cNW surfaces are 
significantly more elongated than the other surfaces, indicating that they may have differentiated 
phenotype. Contractile SMCs in adult blood vessels proliferate at an extremely low rate and 
exhibit low synthetic activity so despite the fact that there are more cells on cNW surfaces; these 
cells may be in a quiescent state. 
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Figure 5.5. Cell viability measured using the MTT assay for SMCs on different surfaces. 
Experiments were replicated on at least three different samples with at least three different cell 
populations (nmin = 9). Statistical significance was calculated using a one-way ANOVA with 
Tukey’s post hoc test. Results indicate after 1 day in culture that SMCs on the cNW surfaces 
have significantly lower MTT reduction than the PCL, NW and cPCL surfaces, whereas, there is 
no significant difference between the PCL, NW and cPCL surfaces. After 7 days in culture, 
SMCs have a significantly higher MTT reduction on cPCL than the PCL, NW and cNW 
surfaces. Further, there were significant differences between PCL, NW and cNW surfaces (PCL 
> NW > cNW). Error bars represent the standard error. 
5.3.4. SMC Morphology on different surfaces 
SMC morphology was investigated using SEM imaging to visualize the cellular 
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been shown to be significant in interactions with biological systems such as proteins and cells 
[34]. Results indicate that there is a clear interaction between SMC’s filopodia and the 
nanofeatures present on both NW and cNW surfaces as well as with the collagen immobilized 
surfaces (cPCL and cNW) (Figure 5.6). After 1 day in culture it is evident that there are SMCs 
present on PCL and cPCL surfaces with a round morphology, as opposed to SMCs adhered on to 
NW and cNW surfaces. Further, confirming fluorescent imaging results, it is apparent that SMCs 
on NW and cNW surfaces seem to be more elongated than those on PCL and cPCL surfaces after 
1 and 7 days of culture. After 7 days in culture SMCs on PCL and cPCL surfaces are no longer 
round, but are still not nearly as elongated as SMCs on NW and cNW surfaces. SMCs do not 
seem to interact as well with PCL surfaces when compared to NW, cPCL and cNW surfaces as 
evident by the clear lack of filopodia. This may be due to the lack of nano-architecture and cell 
binding motifs.  
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Figure 5.6. Representative SEM images of SMCs after 1 and 7 days of culture on different 
surfaces. Note: the surfaces were coated with a 10 nm layer of gold and imaged at 7 keV. 
Experiments were replicated on at least three different samples with at least three different cell 
populations (nmin = 9). 
5.3.5. Differentiation of SMCs on different surfaces 
Expression of SMC contractile proteins is essential to healthy vasculature as 
cardiovascular diseases are characterized by the transition of SMC phenotype from contractile to 
synthetic. During differentiation of SMCs, caldesmon, smooth muscle myosin heavy chain, 
calponin, SM22, #- and ß-tropomyosins, and #l integrin genes are transcriptionally regulated.  
However, in differentiated SMCs transcription of these genes is upregulated in differentiated 






















SMCs, and downregulated in dedifferentiated SMCs [35]. Down-regulation of SMC lineage 
markers has been shown to be associated with calcification [36]. Therefore, differentiation of 
SMCs on surfaces was investigated by detecting CAL and MYH expression both through 
blotting techniques after 7, 14 and 21 days in culture and with immunofluorescence after 21 days 
in culture and western. CAL and MYH are specific to smooth muscle cells and are expressed 
only when smooth muscles cells differentiate into a mature phenotype. CAL is a calcium binding 
protein, located in the thin filaments of smooth muscle. It is present at a stoichiometry of 1 mol 
calponin/7 mol actin [37]. MYH is involved in contraction and is a highly specific marker for the 
SMC lineage. The expression of MYH has never been found in cells other than SMCs in vivo, 
and MYH is the only marker protein that is also SMC specific during embryogenesis [38].  
A western blotting technique was used to partially quantify the presence of MYH and 
CAL on the surfaces. The MYH and CAL expressions were normalized to α–tubulin expression. 
After 7 days in culture, differentiation was investigated without supplying the cells with 
differentiation media. Results reveal that the cells are beginning to differentiate on all surfaces. 
CAL (Figure 5.7.A) and MYH (Figure 5.7.B) expression is significantly higher on NW surfaces 
compared to PCL, cPCL and cNW surfaces, while cNW surfaces express significantly higher 
amounts of CAL and MYH compared to PCL and cPCL surfaces. This indicates that cells are 
significantly more differentiated on nanostructured surfaces at day 7, explaining why MTT 
results were significantly lower on these surfaces. It is important to note that the bands for day 7 
are larger than for days 14 and 21 because more protein lysate was loaded after 7 days in culture, 
compared to after 14 and 21 days in culture. However, all bands were normalized to α-tubulin 
expression to account for this. After 14 days in culture (7 days after providing differentiation 
media), CAL expression is significantly higher on cNW surfaces compared to PCL and NW 
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surfaces. Both collagen immobilized surfaces (cPCL and cNW) express significantly more MYH 
than PCL and NW surfaces, while PCL surfaces expressing significantly more MYH than NW 
surfaces. After 21 days in culture CAL and MYH expression is elevated significantly on cPCL 
and cNW surfaces compared to PCL and NW surfaces. These results are in agreement with a 
study that found collagen type I, type IV and laminin promoted the contractile/differentiated 
phenotype in SMCs [16]. 
Figure 5.7. Western blot analysis of the expression of (A) CAL and (B) MYH on different 
surfaces after 7, 14 and 21 days in culture. Experiments were replicated with western blots with 
at least three different cell populations (nmin = 9). After 7 days in culture NW and cNW express 
significantly more amounts of CAL and MYH compared to PCL and cPCL surfaces, while NW 
surfaces express CAL and MYH significantly more than cNW. After 14 days in culture, CAL 
expression is significantly higher on cNW surfaces compared to PCL and NW surfaces. After 14 
days in culture, both collagen immobilized surfaces (cPCL and cNW) express significantly more 
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NW surfaces. After 21 days in culture CAL and MYH expression is elevated significantly on 
cPCL and cNW surfaces compared to PCL and NW surfaces. 
Immunofluorescence was done after 21 days in culture. Results of immunofluorescence 
indicate that cells on all surfaces are expressing both CAL (Figure 5.8.A) and MYH (Figure 
5.8.B). It is important to note that even with differentiation media the SMCs are proliferating on 
all surfaces but more so on PCL surfaces. Further, SMCs on all surfaces exhibit an elongated 
spindle-shaped morphology.  
 












Figure 5.8. Representative fluorescence microscopy images of SMCs immunostained with (A) 
CAL and (B) MYH. Experiments were replicated on at least three different samples with at least 
three different cell populations (nmin = 9). 
 
5.4. Conclusions  
Inhibition of unnecessary vascular SMC proliferation and preservation of a differentiated 
state in SMCs are important aspects in the management and avoidance of vascular diseases. The 
level of cell functionality on biomaterial surfaces is also correlated to the characteristics of the 
surface and its ability to mimic properties similar to that of extracellular matrix. Therefore, 












providing SMCs with nanotopography and cell-binding motifs such as collagen may affect the 
cell adhesion, viability, morphology and differentiation. In this study, SMCs exhibited increased 
adhesion on NW, cPCL and cNW surfaces, however SMCs on nanostructured surfaces seemed 
to be more elongated than those on PCL surfaces. SEM results also revealed considerable 
amounts of filopodia interacting with surfaces and neighboring cells on NW, cPCL and cNW 
surfaces, but this interaction is lacking on PCL surfaces. The reduction of MTT was higher on 
flat surfaces (PCL and cPCL), indicating a higher rate of proliferation. This suggests that SMCs 
on nanostructured surfaces (NW and cNW) may be in a more differentiated state and slowly 
dividing.  This was confirmed by a significant increase in differentiation markers (CAL and 
MYH) on these surfaces after 7 days in culture without providing cells with differentiation cues. 
After giving the cells differentiation media, SMCs on all surfaces become spindle shaped. 
However the expression of endogenous proteins, CAL and MYH, specific to a contractile SMC 
phenotype is up-regulated on collagen immobilized surfaces (cPCL and cNW). These results 
suggest that nanotopography affects cell proliferation as well as cell elongation, while collagen 
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There are a multitude of polymeric materials such as ultra-high molecular weight 
polyethylene [1], polyether ether ketone [2], and polycaprolactone [3], currently utilized in 
several blood-contacting implantable medical devices such as tissue grafts [4-6], coronary and 
vascular stents [7], and orthopedic implants [8]. Despite how often these devices are used to treat 
tissue or organ failure, all these materials suffer from undesirable blood-material interactions. 
The thrombogenic nature of the material surface can cause serious complications in patients such 
as acute or chronic inflammation, fibrosis, infection and/or thrombosis [9, 10], ultimately leading 
to implant failure [11]. Further, almost all short and long term implanted medical devices that 
come in contact with blood require a considerable amount of anticoagulation treatment which 
comes with a high risk and a high cost to the patient [12]. Current research is focused on 
understanding the interaction of the blood and its components with material surfaces as well as 
developing surfaces that have towards favorable interactions with blood and its components [13-
15]. The ability to regulate immune reactions on a material surface is vital for the success of any 
implantable biomedical device and also determines its hemocompatibility. To this day, there is 
no truly hemocompatible surface [12]. All blood-contacting materials have shown to initiate an 
immunological response. Thus, improving the material surface compatibility with blood and its 
components could eliminate the need for intervention post-implantation. 
 143 
When blood comes in contact with a material surface, an intricate series of highly inter-
connected events, such as platelet and leukocyte adhesion/activation and stimulation of 
complement and coagulation cascades, are initiated and controlled by the surface properties [16]. 
Key blood serum proteins, such as fibrinogen, adsorb and undergo conformational changes on 
the surface, thus mediating these events. Proteins can adsorb on the surface in different 
quantities, densities, conformations, and orientations, depending on the chemical and physical 
characteristics of the surface [17]. The layer of adsorbed proteins influences the adhesion and 
activation of platelets and leukocytes. Activated platelets express proteins such as Platelet 
Factor-4 (PF-4) and P-selectin, which in turn recruits leukocytes on the surface, facilitating the 
formation of platelet/leukocyte complexes. This further stimulates two pathways, better known 
as the intrinsic pathway (contact activation) and the extrinsic pathway (tissue factor), which may 
lead to thrombosis and/or a fibrous capsule. Both pathways involve activation of zymogens, 
eventually converging on a common pathway leading to clot development via formation of 
thrombin and fibrin [18]. Further, red blood cells may also get lysed when in contact with the 
surface, releasing adenosine diphosphate (ADP) which additionally promotes platelet 
aggregation on the material surface [19]. Thus, it is critical to evaluate and understand these 
events on material surfaces. 
There are a variety of biochemical and topographical cues present naturally within human 
tissues that have favorable interactions with blood. Biomimetic surfaces have elicited promising 
cellular responses via biomolecular recognition, which can easily be regulated with changes to 
design parameters of the material surface [20]. Enhanced cellular response to polymers surfaces 
modified with ECM components, such as collagen I are well documented. Collagen I is the main 
component in the ECM of blood vessels as well as other tissues in the body, making it an 
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attractive molecule to modify the material surface. Studies with biofunctionalized collagen 
scaffolds have shown enhanced proliferation and differentiation of neural precursor cells [21], 
improved bioactivity for bone engineering [22, 23] and increased endothelial cell organization 
and cell survival [24]. However, not much is known about the hemocompatibility of collagen 
immobilized surfaces [25, 26]. Further, cells in vivo are constantly interacting with their 
surroundings that are composed of cues at a micrometer and nanometer level [27, 28]. Thus, by 
mimicking this environment in vitro, cell interaction with the surface can be controlled [29-32]. 
Nanostructured material surfaces have shown to elicit appropriate cellular interactions with the 
biomaterial surface such as promotion of an osteoblast phenotype [33, 34], adhesion and 
alignment of smooth cells [35, 36] and enhanced filopodia interactions with the environment 
[37]. Despite all these studies that suggest a correlation between nanoscale surface features and 
cell functionality, there is a limited amount of information in literature about the 
hemocompatibility of nanostructured surfaces [38, 39]. 
In this study, we have evaluated the ability of collagen-immobilized nanostructured 
surfaces as interfaces for blood-contacting materials. Nanowire surfaces were fabricated from 
polycaprolactone using a nanotemplating technique.  Polycaprolactone is used in a multitude of 
FDA approved implants, drug delivery devices, sutures as well as adhesion barriers [40, 41].  
Previous studies have shown that polycaprolactone nanowire surfaces have favorable 
hemocompatible properties and improve cellular functionality [38].  The nanowire surfaces were 
also immobilized with collagen, a protein abundantly found in the extracellular matrix of all 
tissues. Studies have shown enhanced cellular response to these surfaces. Thus, in this study, the 
effect of the collagen immobilization on nanowire surfaces to blood and its components was 
investigated to better understand their effects on hemocompatibility. Fibrinogen binding from 
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blood plasma to the surfaces after 2 hours was investigated using an ELISA. The functionality of 
platelets and leukocytes were investigated on surfaces after 2 hours of contact with whole blood 
plasma using a cell cytotoxicity assay, fluorescence microscopy and scanning electron 
microscopy (SEM). PF-4 release from activated platelets, SC5b-9 and thrombin anti-thrombin 
complexes were quantified using ELISA. Contact activation was characterized via chromogenic 
analysis to determine the amount of kallikrein deposited on the surfaces. Further, a hemolytic 
assay was used to determine erythrocyte lysis. This work provides an in depth look at the 
hemocompatibility of collagen immobilized nanowire surfaces that can lead to further 
development of these surfaces for blood-contacting implantable devices. 
 
6.2. Materials and Methods 
6.2.1. Fabrication of nanostructured surfaces 
Surfaces were fabricated and characterized as described in detail in section 2.2.1 and 
2.2.2. The nanowire surface architecture was examined for uniformity and repeatability using 
SEM imaging.  
 
6.2.2. Plasma isolation from whole blood and incubation on different surfaces 
Whole blood from a healthy individual was drawn into standard 10 ml 
ethylenediaminetetraacetic acid (EDTA) coated vacuum tubes using venipuncture by a 
phlebotomist. To account for the platelet plug and locally activated platelets resulting from the 
needle insertion, the first tube was discarded. The blood vials were centrifuged at 300 g for 15 
min to separate the plasma from the erythrocytes. The plasma was then pooled into fresh tubes 
and allowed to sit for 15 min prior to being used. The surfaces were incubated with 1 ml of 
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pooled plasma in a 24-well plate at 37 °C and 5 % CO2 on a horizontal shaker plate (100 rpm) for 
2 hrs.  
 
6.2.3. Cytotoxicity Assay  
The material cytotoxicity was characterized using a commercially available lactate 
dehydrogenase (LDH) cytotoxicity assay kit (Cayman Chemical). The protocol provided by the 
manufacturer was followed. In brief, the plasma-incubated surfaces were shaken on a horizontal 
shaker plate (1000 rpm) for 5 min at room temperature. The surface-exposed plasma samples as 
well as the standards were transferred to a 96 well plate. A reaction solution consisting of 96% 
v/v assay buffer, 1% v/v NAD+1%, v/v Lactic Acid, 1% v/v INT, and 1% v/v LDH Diaphorase 
was added in equivalent amounts (1:1) to all standards and samples. This solution was incubated 
with gentle shaking on horizontal shaker plate (100 rpm) for 30 min at room temperature. After 
the incubation, the absorbance of the solution was immediately measured at a wavelength of 490 
nm to determine the cytotoxic effects of the different surfaces. 
 
6.2.4. Fibrinogen binding from plasma on different surfaces 
Fibrinogen binding from plasma on different surfaces was investigated using an enzyme-
linked immunoassay (ELISA, GenWay). The protocol provided by the manufacturer was 
followed. In brief, diluted surface-exposed plasma samples (1:200 in assay diluent) and human 
fibrinogen antigen standards were transferred into a microassay well plate and incubated for 60 
mins at room temperature. The samples were removed and the wells were washed (4x) with the 
wash buffer and were incubated with enzyme antibody conjugate for 30 min at room temperature 
without exposure to light. The samples were removed and the wells were washed (4x) with the 
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wash buffer and were incubated with tetramethyl benzidine buffer (TMB) solution for 10 mins at 
room temperature in a dark environment. The reaction was stopped with stop solution and the 
optical density was immediately measured using a spectrophotometer at 450 nm. 
 
6.2.5. Platelet/leukocyte adhesion on different surfaces 
Cellular adhesion on different surfaces was investigated by fluorescence microscopy 
imaging using rhodamine phalloidin cytoskeleton stain and 4’6-diamidino-2-phenylindole- 
dihydrochloride (DAPI). The un-adhered cells were removed by aspirating the plasma from the 
surfaces followed by gently rinsing (2x) with PBS. The surfaces were then transferred to a new 
24-well plate. Cells that adhered to the surfaces were fixed in 3.7 wt % formaldehyde in PBS for 
15 min at room temperature and washed (3x, 5 min each) in PBS. The cell membranes were 
permeabilized using 1 % Triton-X in PBS at room temperature for 3 min. The surfaces were then 
transferred to a new 24-well plate and incubated with 500 µl of rhodamine phalloidin solution in 
PBS for 25 min at room temperature. After 25 min, 0.2 µg/ml DAPI stain was added to each 
well. Following 5 min incubation, the solution was aspirated, surfaces were rinsed with PBS and 
then imaged using a fluorescence microscope (Zeiss). Adherent leukocytes on 50x images were 
counted. All images were processed using ImageJ Software.  
 
6.2.6. Platelet/leukocyte morphology on different surfaces 
The platelet-leukocyte morphology and interaction with the surfaces was investigated 
using SEM imaging. The un-adhered cells were removed by aspirating the plasma from the 
surfaces followed by gently rinsing (2x) with PBS. The surfaces were then transferred to a glass 
petri-dish and the platelets and leukocytes that adhered were fixed by incubation in a solution of 
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primary fixative (6 % gluteraldehyde (Sigma), 0.1 M sodium cacodylate (Polysciences), and 0.1 
M sucrose (Sigma)) for 45 min. The surfaces were then transferred to a secondary fixative 
(primary fixative without gluteraldehyde) for 10 min. The surfaces were then placed in 
consecutive solutions of ethanol (35 %, 50 %, 70 % and 100 %) for 10 min each. For further 
dehydration, surfaces were placed into a solution of hexamethyldisilazane (HMDS, Sigma) for 
10 min. The surfaces were then air-dried and stored in a desiccator until further imaging by 
SEM. Prior to imaging, the substrates were coated with a 10 nm layer of gold and imaged at 7 
kV.  
 
6.2.7. Platelet/leukocyte detection on different surfaces by immunofluorescence and western 
blotting 
Immunofluorescence staining and a western blotting technique were used to determine 
the cellular expression of proteins exclusive to platelets and leukocytes. The un-adhered cells 
were removed by aspirating the plasma from the surfaces followed by gently rinsing (2x) with 
PBS. The surfaces were then transferred to a new 24-well plate and adherent cells were fixed in 
3.7 wt% formaldehyde in PBS for 15 min at room temperature and washed (3x 5 min) in PBS. 
The cell membranes were permeabilized using 1 % Triton-X in PBS at room temperature for 3 
min, followed by washing with PBS (3x, 5mins each). The surfaces were then incubated in a 
blocking solution (10 % BSA in PBS) for 30 min at room temperature. The surfaces were 
washed (3x, 5 mins each) in PBS and incubated in primary antibodies specific to platelets and 
leukocytes, P-Selectin and CD45 respectively (dilution 1:50, Santa Cruz Biotechnology) in a 
solution of 2 % BSA in PBS for 1 hr at room temperature. The surfaces were placed in new 24-
well plates then washed (3x, 5 min each) in PBS, and incubated with fluorescently-labeled 
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secondary antibodies, donkey anti-goat conjugated with Texas Red (for P-Selectin) and chicken 
anti-mouse conjugated with FITC (for CD45) (dilution 1:100, Santa Cruz Biotechnology) in a 
solution of 2 % BSA in PBS for 1 hr at room temperature. The surfaces were washed (3x, 5 mins 
each) in PBS and imaged with a fluorescence microscope (Zeiss). All images were processed 
using ImageJ Software.  
Western blotting was performed to partially quantify the expression of P-Selectin and 
CD-45. Briefly, the cells adhered on surfaces after 2 hrs of incubation in whole blood plasma 
were homogenized in RIPA lysis buffer (10.0 mM Tris pH 7.4, 100.0 mM NaCl, 5.0 mM EDTA, 
5.0 mM EGTA, 1.0% Deoxycholate, 0.1% SDS, 1.0% Triton X-100) containing protease 
inhibitor cocktail. The lysate protein content was determined by micro-BCA assay. The lysate 
was heated to 95 °C for 10 mins in sample buffer (62.5 mM Tris-HCl pH 6.8, 10.0 % glycerol, 
5.0 % β-mercaptoethanol, 2.0% SDS, 0.025 % Bromophenol blue) in order to denature the 
proteins prior to gel loading. 20 µg of total extract protein was electrophoresed through 8 % Tris-
SDS gels and transferred to PVDF membranes in 7.5 % methanol. Blots were blocked for 1 hr at 
room temperature in 10 % BSA solution. Primary monoclonal antibodies for P-selectin and CD-
45 were diluted 1:500 in 3% BSA in PBS-tween solution and incubated overnight at 4 °C. The 
blots were then washed with PBS-tween solution (3x, 5 mins) before they were incubated with 
goat anti-mouse or donkey anti-goat horseradish peroxidase (HRP) conjugated secondary 
antibodies (Santa Cruz Biotechnology) at a dilution of 1:5000 for 1 hr at room temperature. The 
blots were then washed with PBS-tween solution (3x, 5 mins) followed by protein detection 
using chemiluminescence (WestPico Chemiluminescent Substrate, Pierce).  The blots were 
imaged using an Alpha Innotech Fluorchem gel documentation system, and band intensities were 
analyzed using ImageJ software. 
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6.2.8. PF-4 Expression on different surfaces 
PF-4 expression was measuresd using a commercially available enzyme linked 
immunosorbant assay kit (ELISA, RayBio) to evaluate platelet activation on different surfaces. 
The protocol provided by the manufacturer was followed. In brief, diluted substrate-exposed 
plasma samples (1:200 in assay diluent) and PF-4 standards were transferred into a microassay 
well plate and incubated for 2.5 hrs on a horizontal shaker plate (100 rpm) at room temperature. 
The wells were washed (4x) with wash buffer, and incubated with biotinylated antibody for 1 hr 
on a horizontal shaker plate (100 rpm) at room temperature. The wells were then washed (4x) to 
remove unbound biotinylated antibody.  This was followed by incubating the wells with a 
horseradish peroxidase (HRP)-streptavidin solution (1:25,000 in assay diluent) and incubated for 
45 mins on a horizontal shaker plate (100 rpm) at room temperature. Wells were then washed 
(4x) with the wash buffer. The TMB solution was then immediately added to each well and 
incubated for 30 mins on a horizontal shaker plate (100 rpm) at room temperature with no 
exposure to light. The reaction was stopped with a stop solution and the optical density of the 
resulting solution was measured immediately thereafter at 450 nm to determine the amount of 
PF-4 released by platelets on each of the substrates.  
 
6.2.9. Contact activation on different surfaces 
In order to investigate contact activation on different surfaces, the degree of plasma 
kallikrein expression (Chromogenix) present on surface-exposed plasma was evaluated with an 
acid stop method. The protocol provided by the manufacturer was followed. In brief, the surface-
exposed plasma samples were diluted 10 fold in Tris Buffer (pH 7.8). 100 µl of each diluted 
surface-exposed plasma sample was placed in a 96-well plate and incubated at 37 °C and 5 
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%CO2 for 3-4 mins. 100 µl of pre-warmed (37 °C) substrate solution was added to all the 
samples and incubated at 37 °C and 5 %CO2 for 10 mins.  The reaction was stopped by 100 µl of 
20 % acetic acid to all samples. Plasma blanks were prepared by adding reagents in reverse 
order, without incubation. The optical density of samples was measured at 405 nm using a 
spectrophotometer to determine the degree of contact activation on the different surfaces. 
 
6.2.10. Complement activation on different surfaces 
Complement activation was evaluated on different surfaces using an enzyme 
immunoassay (EIA, Quidel Corporation) to evaluate SC5b-9 complement activation. The 
protocol provided by the manufacturer was followed. In brief, microassay wells were rehydrated 
by incubating in a wash solution for 2 mins at room temperature. Wash solution was aspirated 
and 100 µl of diluted surface-exposed plasma samples (1:10 in assay diluent), standards and 
controls were transferred into microassay wells and incubated for 60 mins at room temperature. 
The wells were washed (5x) with wash buffer and incubated in SC5b-9 plus conjugate for 30 
mins at room temperature. Wells were then washed (5x) with wash buffer, followed by 
incubation in TMB solution for 15 mins at room temperature without exposure to light. The 
reaction was stopped with stop solution and optical density was measured at 450 nm with a 
spectrophotometer to determine the amount of SC5b-9 complement activation present on the 
different surfaces.  
 
6.2.11. Thrombin anti-thrombin (TAT) complex formation on different surfaces 
Thrombin anti-thrombin (TAT) concentration was measured using a thrombin anti-
thrombin human ELISA kit (HaemoScan). The protocol provided by the manufacturer was 
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followed. In brief a Nunc Maxisorp 96-well microtiter plate was coated with capture antibody in 
coating buffer overnight at 2-8 °C. The plate was washed (3x) with PBS-Tween wash buffer. 100 
µl of surface-exposed diluted plasma samples (1:200) along with standards were placed into the 
wells and incubated for 1 hr at room temperature. The wells were washed (3x) before 100 µl of 
detection antibody solution was added and incubated at room temperature for 1 hr. The wells 
were washed (3x) and 100 µl of substrate solution was added. After 20 mins the reaction was 
stopped with 50 µl of stop solution and optical density was read at 450 nm with a 
spectrophotometer. 
 
4.2.12. Thrombin generation on different surfaces 
The rate of thrombin generation on different surfaces was calculated using a thrombin 
generation assay (TGA) (HaemoScan). The protocol supplied by the manufacturer was followed. 
In brief, all surfaces were incubated in 350 µl diluted TGA plasma for 15 mins. 175 µl of a 
prepared mixture of TGA reagent A and TGA reagent B was added to each vial. After 1 min, 10 
µl of this mixture was placed into a vial containing 490 µl buffer B. Vials were immediately 
placed back in the water bath after sampling. This was repeated after 2 min, 4 min, and 6 min for 
each sample and reference material. 150 µl of samples from each surface and standards were 
placed into a 96-well plate and incubated for 2 min at 37 °C and 5 %CO2. 50 µl of diluted 
substrate solution was added to each well and the covered well plate was incubated for 20 min at 
37 °C and 5 %CO2. 50 µl of stop solution was added to each well and optical density was read 
immediately at 405 nm, using 540 nm as a reference wavelength. Thrombin generation rate was 
calculated by determining the highest velocity between the two measured time points and 
correcting for the dilution factor (50x). 
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6.2.13. Hemolytic activity on different surfaces 
Hemolytic activity of different surfaces was investigated using a biomaterial hemolytic 
assay (HaemoScan). The protocol supplied by the manufacturer was followed. In brief, cleaned 
surfaces along with reference materials were placed in syringes. One syringe without material 
was used as a negative control. An erythrocyte suspension (500 µl) was added to each syringe 
with specimen (test material, reference material or negative control). Air was removed and 
parafilm was used to close the outlet. Vials were incubated at 37 °C for 24 hrs while subjected to 
end-over end rotating. The erythrocyte suspension was carefully transferred to a centrifuge tube 
(1.5 mL) followed by centrifugation at high speed (3600g) for 1 min. 20 µL of supernatant from 
each sample or standard was placed into a 96-well plate along with 180 µL of assay buffer. The 
96-well plate was mixed on a shaker plate before measuring optical density at 415nm. 
 
6.2.14. Statistical Analysis 
Each qualitative experiment was performed on at least three different surfaces with at 
least three different whole blood plasma populations (nmin = 9). All ELISA and EIA experiments 
were done on five surfaces. Further, all of the quantitative results were evaluated using one-way 
analysis of variance (ANOVA) with a Tukey’s post-hoc test. Statistical significance was 
considered at p < 0.05.  
 
6.3. Results and Discussion 
 To this day, there is no truly hemocompatible surface that has appropriately interacts with 
blood and its components [12]. All blood-contacting materials continue to induce unfavorable 
responses to whole blood and its components, such as protein adsorption, platelet and leukocyte 
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adhesion/activation and stimulation of complement and coagulation cascades. These 
complications can potentially lead to implant failure and can limit the long-term success of 
blood-contacting devices. Thus, in this study we have evaluated the effect of collagen 
immobilization to nanowire surfaces on blood and its components to better understand their 
effects on hemocompatibility. Improving the material surface compatibility with blood and its
components could eliminate the need for intervention post-implantation. 
 
6.2.1. Fabrication and characterization of PCL NW and NF surfaces 
Surfaces were fabricated and characterized as described in detail in section 2.2.1 and 
2.2.2. The nanowire surface architecture was examined for uniformity and repeatability using 
SEM imaging (Figure 6.1.).  
 
Figure 6.1. Representative SEM images of unmodified and collagen-immobilized PCL and NW 




6.3.2. Cytotoxicity Assay  
The material cytotoxicity was investigated after 2 hours of incubation in whole blood 
plasma using a commercially available lactate dehydrogenase (LDH) assay kit. LDH is a soluble 
enzyme located inside the cytoplasm of cells that is released upon loss of membrane integrity 
due to apoptosis or necrosis. Thus this enzyme acts as a good marker of cell membrane integrity 
and can be used to evaluate the cytotoxic effects of the surfaces in this study. This assay 
measures the amount of formazan following a two-step reaction, where first LDH catalyzes 
NAD+ to NADH and H+ by oxidation and a subsequent reaction by diaphorase converts the 
tetrazolium salt to a colored formazan. Formazan absorbs strongly at 490-520 nm, therefore the 
amount of LDH released can be determined using a spectrophotometer. These measurements 
indicate the level of cytotoxicity. The results indicate all the surfaces demonstrate a comparable 
cytotoxicity on platelets/leukocytes (Figure 6.2). Thus, none of the surfaces progress short-term 
cytotoxic effects on the components of whole blood plasma. It is well known that 
polycaprolactone is nontoxic and is also approved by the FDA for use in several implantable 
devices [42]. The results here indicate that topographical and biomolecular modifications to 
polycaprolactone does not significantly alter the cytotoxicity of resulting surfaces. 
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Figure 6.2. Cell cytotoxicity measured using an LDH Assay on different surfaces after 2 hours 
of incubation in whole blood plasma. The results indicate no significant difference in LDH 
activity on all the surfaces. Experiments were replicated with at least three different cell 
populations on at least three different samples (nmin = 9). Error bars represent standard error. 
6.3.3. Fibrinogen binding from plasma on different surfaces 
Fibrinogen, produced by the liver, is present in blood plasma at a concentration of 200-
400 mg/dL. Fibrinogen has two roles in the blood clotting cascade. It yields monomers that can 
polymerize into fibrin and is a cofactor in platelet aggregation. Prothrombin initiates the 
coagulation cascade when it is proteolytically cleaved to form thrombin. Thrombin then acts as a 
serine protease, which converts fibrinogen into fibrin. Under normal conditions, polymeric fibrin 
fibers form a thrombus network, also known as a blood clot. This clot can be characterized by 
the strength of the fibrin network that captures many components of blood. In order to evaluate 
the pro-coagulant activity, fibrinogen binding from blood plasma on different surfaces was 
evaluated after 2 hours of incubation using commercially available human fibrinogen antigen 
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assay. The plasma exposed to different surfaces was assayed to determine the amount of 
fibrinogen that was not bound on the material surface. The results indicate a significantly higher 
concentration of fibrinogen in the NW and cNW exposed whole blood plasma compare to that of 
PCL exposed whole blood plasma (Figure 6.3.). This indicates significantly lower amount of 
fibrinogen binding on NW and cNW surfaces compared to PCL surfaces. Fibrinogen includes 
both hydrophobic and hydrophilic regions, giving it amphiphilic properties [43].  This allows it 
to bind on to a plethora of surfaces. However, blood plasma proteins have a higher affinity for 
binding unto uncharged hydrophobic surfaces as opposed to hydrophilic surfaces [44, 45]. PCL 
surfaces are significantly more hydrophobic compared to NW and cNW surfaces, thus binding 
significantly more amount of fibrinogen compared to NW and cNW surfaces. However, the 
conformation and/or orientation of bound fibrinogen on the material surface plays a major role in 
determining its biocompatibility as well. It was found that platelet adhesion to biomaterial 
surfaces increases with increased coverage of fibrinogen only if the bound fibrinogen maintains a 
conformation so that its functional domain is recognizable by antibody probes [46]. The results 
from fibrinogen binding indicate that nanostructured surfaces may reduce fibrin clot formation, 
further promoting material hemocompatibility.  
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Figure 6.3. Human fibrinogen antigen concentration measured on surfaces after 2 hours of 
incubation in whole blood plasma. The results indicate a significantly higher concentration of
fibrinogen in the NW and cNW exposed whole blood plasma compare to that of PCL exposed 
whole blood plasma, indicating significantly lower amount of fibrinogen binding on NW and 
cNW surfaces compared to PCL surfaces. Experiments were replicated with at least three 
different cell populations on at least three different samples (nmin = 9). Error bars represent 
standard error. 
6.3.4. Platelet/leukocyte adhesion on different surfaces 
Cellular adhesion on different surfaces was investigated by fluorescence microscope 
imaging using rhodamine phalloidin cytoskeleton stain and DAPI nucleus stain to identify 
adherent platelets and leukocytes. Rhodamine phalloidin stained the cytoskeleton of both 
platelets and leukocytes. However, DAPI stained selectively for leukocytes as platelets are 
anuclear. The activated platelets can bind to each other as well as interact with leukocytes by 
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binding to them, producing mixed aggregates. This platelet aggregation can be visualized using 
fluorescence microscopy. The results indicate lower cell adhesion and minimal platelet 
aggregation on NW surfaces as compared to PCL, cPCL and cNW surfaces (Figure 6.4.). 
Further, results also indicate higher cell adhesion on PCL surfaces followed by cNW and cPCL 
surfaces.  However, there was minimal platelet aggregation observed on PCL surfaces as 
compared to cNW and cPCL surfaces. Upon platelet aggregation, micro-platelet membrane 
particles are released, further promoting plasma coagulation [47]. Thus, the results indicate that 





Figure 6.4. Representative fluorescence microscope images of adhered platelets and leukocytes 
stained with rhodamine-conjugated phalloidin (cytoskeleton) and DAPI (nucleus) on different 
surfaces after 2 hours of incubation in whole blood plasma. The images indicate a decrease in 
cell adhesion and platelet aggregation on NW surfaces.  
Further, the fluorescence microscopy images were used to calculate the number of 
adhered leukocytes on different surfaces. The number of platelets could not be calculated due to 
higher degree of aggregation on the surfaces. The results indicate that there is no significant 
difference in leukocyte adhesion on the different surfaces (Figure 6.5.). 
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Figure 6.5. Adhered leukocytes after 2 hours of incubation in whole blood plasma on different 
surfaces. No significant differences in leukocyte adhesion was seen on different surfaces. 
Experiments were replicated with at least three different cell populations on at least three 
different samples (nmin = 9). Error bars represent standard error. 
6.3.5. Platelet/leukocyte morphology on different surfaces 
Platelet and leukocyte morphology, aggregation and interaction on different surfaces 
were investigated using SEM imaging.  The results indicate a decrease in platelet aggregation on 
NW surfaces as compared to PCL, cPCL and cNW surfaces (Figure 6.6.). High magnification 
SEM images reveal increased platelet aggregation on cPCL surfaces followed by PCL and cNW 
surfaces. Further, the SEM images also show no platelet/leukocyte interaction and complex 
formation on NW followed by minimal platelet/leukocyte interaction and complex formation on 
cNW surfaces.  However, there is increased platelet/leukocyte interaction and complex formation 
on PCL and cPCL surfaces. Platelet/leukocyte interaction and complex formation appears to 
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promote activation of platelets as evident by their altered morphology and dendritic extensions 
on PCL and cPCL surfaces. This platelet/leukocyte interaction is a reliable marker of a 
prothrombotic state and mixed aggregates are linked to several cardiovascular conditions [48]. 
Leukocytes may influence coagulation either directly, by producing procoagulant and 
anticoagulant molecules, or indirectly, by acting on vascular cells such as platelets, endothelial 
cells, and other leukocytes [49]. Studies have also shown that platelets-leukocyte interaction may 
also result in increased tissue factor (TF) expression, leading to fibrin deposition [50]. Thus, the 
results presented here indicate that NW surfaces may be more hemocompatible with lower 
probability for thrombogenic effects. The results also indicate that cNW surfaces may also 




Figure 6.6. Representative SEM images of adhered platelets and leukocytes on different surfaces 
after 2 hrs of incubation in whole blood plasma. The surfaces were coated with a 10 nm layer of 
gold and imaged at 5-7 kV. Images show a lower degree of platelet/leukocyte interaction and 
cellular aggregation on NW surfaces.  
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6.3.6. Platelet/leukocyte detection on different surfaces by immunofluorescence and western 
blotting 
Platelet/leukocyte interaction and complex formation promotes further activation of 
platelets and leukocytes, advancing the coagulation cascade. In this study, platelet and leukocyte 
activation was investigated after 2 hours of incubation in whole blood plasma by 
immunofluorescence staining and a western blotting technique for specific marker proteins, P-
selectin and CD-45, that are known to be expressed in activated platelets and leukocytes 
respectively. P-selectin expression by platelets plays an essential role in the initial recruitment of 
leukocytes to the site of inflammation, further promoting fibrin deposition. It then promotes 
platelet aggregation via platelet-fibrin or platelet-platelet binding. CD-45 is a transmembrane 
protein present on all human leukocytes and plays a role in signal transduction. CD-45 has found 
to be not expressed by platelets. The results indicate a decrease in both P-selectin (TR-
conjugated) and CD45 (FITC-conjugated) expression on NW and cNW surfaces compared to 
PCL and cPCL surfaces (Figure 6.7.(a)). Further, a western blot technique was used to partially 
quantify the expression of P-selectin and CD45 on the surfaces. The results confirm the 
immunofluorescence images indicating a significant increase in P-Selectin and CD-45 expression 
on cPCL surfaces compared to PCL, NW and cNW surfaces (Figure 6.7.(b)). P-Selectin 
expression was also significantly higher on PCL surfaces compared to NW and cNW surfaces. 
Leukocytes adhere to the surface of an implanted biomaterial following platelet adhesion and 
activation in order to defend the body against foreign materials and this recruitment of 
leukocytes can cause further thrombogenic effects. Upon activation, leukocytes release granules, 
allowing them to easily adhere to collagen. Thus, increased adhesion and activation of platelets 
results in increased P-selectin expression on PCL and cPCL surfaces, which further promotes 
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more leukocyte recruitment resulting in increased CD45 expression.  Further, the cPCL surfaces 
provide signals to leukocytes, which further promotes their adherence.   
 
Figure 6.7.(a). Representative fluorescence microscope images of platelets immunostained for 
P-Selectin and leukocytes immunostained for CD45 on different surfaces after 2 hours of 
incubation in whole blood plasma. The images indicate a considerable reduction in P- Selectin 
(TR-conjugated) and CD45 (FITC-conjugated) expression on NW and cNW surfaces compared 
to PCL and cPCL surfaces. 
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Figure 6.7.(b). Western blot analysis of P-Selectin and CD-45 expression on different surfaces 
after 2 hours of incubation in whole blood plasma. Results indicate significant increase in P-
Selectin and CD-45 expression on cPCL surfaces compared to PCL, NW and cNW surfaces. P-
Selectin expression was also significantly higher on PCL surfaces compared to NW and cNW 
surfaces. Experiments were replicated with at least three different cell populations on at least 
three different samples (nmin = 9). Error bars represent standard error. 
6.3.7. PF-4 Expression on different surfaces 
To further quantify platelet activation, the amount of PF-4 present in surface-exposed 
plasma samples was investigated. PF-4 is released from alpha-granules in activated platelets 
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during aggregation in a platelet release reaction. PF-4 is therefore an excellent indicator of 
platelet activation. A human PF-4 ELISA was used to quantify the amount of PF-4 released by 
activated platelets after 2 hours of incubation in whole blood plasma. The results indicate a 
significant increase in PF-4 expression on cPCL surfaces compared to NW and cNW surfaces,
and a significant decrease in PF-4 expression on NW surfaces compared to PCL and cPCL 
surfaces (Figure 6.8.). Platelet activation and release of biomolecules such as PF-4 from 
activated platelets is influenced by the presence and interaction of leukocytes with platelets [10].  
Further, the lower release of PF-4 from platelets after being exposed to NW and cNW surfaces 
may be due to the decrease in platelet/leukocyte interaction and complex formation (Figure 
6.6.). 
 
Figure 6.8. Platelet release reaction measured by the amount of PF-4 released from !- granules 
within the platelets on different surfaces after 2 hours of incubation in whole blood plasma. The 
results indicate a significant increase in PF-4 expression on cPCL surfaces compared to NW and 
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cNW surfaces and a significant decrease in PF-4 expression on NW surfaces compared to PCL 
and cPCL surfaces. Experiments were replicated with at least three different cell populations on 
at least three different samples (nmin = 9). Error bars represent standard error. 
 
6.3.8. Contact activation on different surfaces 
Contact activation has been considered a significant cause for insufficient 
hemocompatiblity of blood-contacting biomaterials because it is initiated by blood-biomaterial 
contact [51]. The proteins involved in the contact activation system such as factors VII, IX, XI, 
XII, prekallikrein and high molecular weight kininogen, have functions of being profibrinolytic, 
anti-adhesive, anti-coagulant and pro-inflammatory [52]. The degree of contact activation on the 
different surfaces after 2 hours of incubation in whole blood plasma was determined by 
measuring the activity of the kallikrein-a2-macroglobulin complex. Unlike factor XIIa, all 
kallikrein is released from the surface of the biomaterial. The results indicate no significant 
difference in contact activation on all the surfaces (Figure 6.9.). This may be due to the fact that 




Figure 6.9. Contact activation measured by the amount of kallikrein on different surfaces after 2 
hours of incubation in whole plasma. The results indicate no significant difference in contact 
activation on the surfaces. Experiments were replicated with at least three different cell 
populations on at least three different samples (nmin = 9). Error bars represent standard error. 
6.3.9. Complement activation on different surfaces 
The complement system, consisting of over 20 plasma proteins, such as C3 and C5, plays 
a significant role in the body's defense mechanisms against infection and “foreign” objects and 
supports the innate immune system [16, 53]. Complement activation facilitates antibodies and 
phagocytic cells when clearing pathogens from an organism. The main functions are 
opsonization, chemotaxis, cell lysis and aggregation of antigen-bearing agents. There are three 
pathways of complement activation, which converge to form the terminal complement complex 
(TCC) or SC5b-9 complex [54]. The surface of an implant may activate an inflammatory 
reaction leading to the formation of the SC5b-9 complex. Therefore quantifying this complex 
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provides an accurate measurement of the degree of complement activation occurring in response 
to a material surface. In this study, a quantitative SC5b-9 EIA analysis was performed after 
surfaces were exposed to whole blood plasma for 2 hours (Figure 6.10.). The results indicate no 
significant difference in SC5b-9 complex formation in response to the different surfaces 
indicating a similar inflammatory response. This indicates that altering the topography of PCL 
does not significantly increase the activation of the complement system.  
 
Figure 6.10. Complement activation measured by the amount of SC5b-9 activation on different 
surfaces after 2 hours of incubation in human plasma. The results indicate no significant 
difference in the level of complement activation. Experiments were replicated with at least three 
different cell populations on at least three different samples (nmin = 9). Error bars represent 
standard error. 
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6.3.10. Thrombin anti-thrombin (TAT) complex formation on different surfaces  
Thrombin, one of the key enzymes in the coagulation cascade, is known to promote the 
activation and aggregation of platelets. Thrombin also has a short half-life, making it difficult to 
determine its activity. Upon activation of the coagulation cascade, prothrombin is activated into 
thrombin. The primary inhibitor of thrombin is anti-thrombin and it forms a complex known as 
the thrombin anti-thrombin (TAT) complex. The TAT complex has been used as a marker for 
thrombin generation. The ability for the different surfaces to affect intrinsic coagulation cascade 
turnover for thrombin generation was investigated with a TAT ELISA. The results indicate a 
significant decrease in TAT concentration on NW surfaces compared to PCL, cPCL and cNW 
surfaces, and an significant increase in TAT concentration on cPCL surfaces compared to PCL, 
NW and cNW surfaces (Figure 6.11.). These results are in agreement with platelet activation 
results (Figure 6.7. and 6.8.). Thrombin generation ultimately leads to platelet activation, and an 
increase in platelet activation was observed on cPCL surfaces, while there was a decrease in 
platelet activation was observed on NW surfaces.  
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Figure 6.11. TAT concentration determined after 2 hours of incubation of different surfaces in 
whole blood plasma. Results indicate a significant decrease in TAT concentration on NW 
surfaces compared to PCL, cPCL and cNW surfaces and an increase in TAT concentration on 
cPCL surfaces compared to PCL, NW and cNW surfaces. Experiments were replicated with at 
least three different cell populations on at least three different samples (nmin = 9). Error bars 
represent standard error. 
6.3.11. Thrombin generation on different surfaces 
Further, the velocity of thrombin generation on different surfaces was calculated using a 
thrombin generation assay (TGA). Thrombin promotes platelet activation and aggregation and is 
one of the key enzymes in the coagulation cascade. Thrombin has a short half-life, which makes 
it difficult to accurately determine its activity. HaemoScan’s assay uses a special plasma product 
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in order to determine thrombin activity and this method is suited to evaluate haemocompatibilty 
of biomaterials and medical devices. 
Results indicate that thrombin generation velocity was greatest on cNW surfaces over a 
period of 6 mins, followed by cPCL surfaces, with NW surfaces having the lowest thrombin 
generation velocity (Figure 6.12.). It is important to note that this assay was done over the 
course of 6 mins while the previous assay determined TAT complex formation after 2 hrs. These 
combined results indicate that the initial generation of thrombin is greatest on cNW surfaces, 
however, after 2 hrs TAT complex formation is significantly higher on cPCL surfaces.  
 
Figure 6.12.  (A) Thrombin generation profile was measured with a spectrophotometer after 1 
min, 2 mins, 4 mins and 6 mins. (B) Thrombin generation velocity was calculated as the largest 
difference between two points and normalized to area of each surface. No statistics were done as 
this experiment was only performed once. 
6.3.12. Hemolysis on different surfaces 
Hemolytic activity of different surfaces was investigated using a biomaterial hemolytic 
assay. Hemolytic activity is required to be tested for any blood contacting medical device. The 
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assay is centered on erythrocyte lysis, which can be induced by a variety of reasons such as 
contact, leachables, toxins, metal ions, surface charge or any other cause of erythrocyte lysis. 
The membranes of red blood cells undergo dynamic stress when exposed to a biomaterial and are 
considered fragile. The assay measures release of hemoglobin spectrophotometrically. Further, 
this assay is suited to evaluate the haemocompatibility of biomaterials and medical devices 
according to the international standard ISO 10993-4:2002. The results indicate a significant 
increase in the amount of hemoglobin released on PCL surfaces indicating more hemolysis 
compared to NW, cPCL and cNW surfaces (Figure 6.13.). This is undesirable since erythrocytes 
contain adenosine diphosphate (ADP), which is released when they are lysed resulting in further 
platelet aggregation [19]. Studies have shown that material surfaces with the high contact angles 
and high work of adhesion cause more lysis of erythrocytes [55]. PCL surfaces have the highest 
contact angles compared to cPCL, NW and cNW surfaces, which may be why significantly more 





Figure 6.13. Hemoglobin release from an erythrocyte suspension was measured with a 
spectrophotometer after an incubation period of 24 hrs. Results indicate a significant increase in 
the amount of hemoglobin released on PCL surfaces compared to NW, cPCL and cNW surfaces.
Experiments were replicated with at least three different cell populations on at least three 
different samples (nmin = 9). Error bars represent standard error. 
6.4. Conclusion  
The thrombogenic effects of four different surfaces (PCL, NW, cPCL, cNW) were 
investigated for their use as interfaces for blood-contacting implants. This study sheds light on 
the intricate relationship of blood-biomaterial interactions.  The clotting cascade consists of 
many pathways that eventually converge to a common pathway and lead to the formation of a 
blood clot.  It is important to understand how components of the clotting cascade will interact 
with a biomaterial surface in order to be able to produce a truly biocompatible implant surface. 
The results presented her indicate a decrease in thrombogenic effects on NW surfaces compared 
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to PCL, cPCL and cNW surfaces. Proteins found in plasma, such as thrombin and fibrinogen, 
molecules released from platelets and leukocytes and collagen are known to be potent platelet 
activators [16]. Findings from this study show that even surfaces coated with collagen did not 
produce fully activated platelets alone, but did produce more platelet aggregation, which is a 
very interesting finding. Although there were no significant differences in leukocyte adhesion, 
there was a decrease in platelet adhesion on NW surfaces. SEM images showed a decrease in 
platelet/leukocyte complexes on cNW surfaces and no apparent complexes were formed on NW 
surfaces compared to PCL and cPCL surfaces.  The increase in these complexes likely 
contributed to a higher expression of specific markers for platelet and leukocyte activation on 
PCL and cPCL surfaces. No significant differences were found in contact and complement 
activation. Further, thrombin anti-thrombin complexes were significantly reduced on NW 
surfaces. A significant increase in hemolysis and fibrinogen adsorption was identified on PCL 
surfaces likely caused by its hydrophobic surface. Further studies are now directed towards 
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CO-CULTURE OF ENDOTHELIAL AND SMOOTH MUSCLE CELLS ON 
POLYCAPROLACTONE NANOWIRE SURFACES 
 
7.1. Introduction 
Stents and vascular grafts have been used routinely for treatment of cardiovascular 
diseases. Unfortunately, re-endothelialization of biomaterials used for these cardiovascular 
implants is still a major concern [1]. The communication between cells is essential for the normal 
maintenance of tissue and a number of pathophysiological responses [2]. In particular, 
cardiovascular tissue requires interactions between the endothelium with the underlying smooth 
muscle cells (SMCs), which is vital for cardiovascular health and is considered to be important in 
the functions of blood vessels [3, 4]. Maintenance of arterial structure relies on this interaction. 
ECs and SMCs act as a linked system for the communication of signals from receptors confined 
on the endothelium surface to the arterial wall and vice versa. It has been shown that 
bidirectional electrical signals flow in response to kinins between ECs and SMCs [5]. ECs and 
SMCs in the vascular wall can also communicate through the release of signals into the 
surrounding medium, or via direct cell-cell contact through junctions formed between the cells 
[6]. For example, during vasculogenesis, growth factors released from ECs promote migration of 
undifferentiated mesenchymal cells towards ECs and upon contact with ECs the mesenchymal 
cells differentiate into SMCs [7].  
Further, in order to prevent thrombosis, restenosis and ultimate failure of the implant, an 
intact endothelium at the vessel-biomaterial interface is fundamental, in turn also preventing 
over-proliferation of the smooth muscle cells. ECs produce both growth inhibitors and 
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stimulators of SMCs. In particular nitric oxide (NO), released by ECs, is responsible for 
inhibiting the proliferation of SMCs via the extracellular signal-regulated kinase (ERK) pathway 
[8]. Studies have also shown that the rate of proliferation of SMCs is directly dependent on the 
state of endothelium [9]. When the endothelium is in a confluent state, the normal growth rate of 
SMCs is completely inhibited. Further, ECs cultured with synthetic state SMCs separated by a 
porous membrane demonstrated increased EC adhesion molecule expression, suggesting that 
synthetic SMCs activate the endothelium [10]. 
In this study we attempted to improve endothelialization while limiting over-proliferation 
of smooth muscle cells on poly(ε-caprolactone), a polymer often used in artificial vessel 
development [11-13]. This surface was immobilized with collagen, a key component of vascular 
tissue. In order to provide insights into the material surfaces’ feasibility for use as an interface in 
cardiovascular applications, we are using human microvascular endothelial cells and human 
aortic smooth muscle cells to test surface-functionalized poly(ε-caprolactone) for its cell 
stimulatory potential. 
 
7.2. Materials and Methods 
7.2.1. Fabrication and characterization of PCL and NW surfaces. 
Surfaces were fabricated and characterized as described in detail in section 2.2.1 and 2.2.2. 






7.2.2. Human Aortic Smooth Muscle Cell and Human Microvascular Endothelial Cell 
Culture 
Both human aortic SMCs (Life Technologies) and human microvascular ECs were 
suspended in MCDB 131 media (Life Technologies) enhanced with SMC growth supplement 
or microvascular growth supplement, respectively (both supplemented with 2 mmol/l 
glutamine, 100 ug/ml penicillin, and 100 ug/ml streptomycin) and added to 75 cm2 culture 
flasks and incubated at standard culture conditions. This study was performed using SMCs that 
were passage 4 and ECs at passage 5.  
First, SMCs were cultured on PCL, NW, cPCL and cNW surfaces in a 48-well plate. 
Prior to seeding, all surfaces were subjected to 30 min UV exposure and conditioned for 5 min 
in 400 μl of culture medium. The SMCs were seeded at a high density of 5 × 106 cells/well. 
The surfaces were incubated in standard culture conditions in 400 μl of cell rich medium and 
allowed to adhere for 24 hrs. After 24 hrs in culture, the ECs were seeded at a high density of 
5 × 106 cells/well on top of the adhered SMCs. After 24 hrs of co-culture, media changes were 
done with MCDB 131 media enhanced with with SMC differentiation supplement 
(supplemented with 2 mmol/l glutamine, 100 ug/ml penicillin, and 100 ug/ml streptomycin). 
Cellular adhesion and morphology was investigated after 7 days in culture. Cellular 
differentiation was investigated after 7 and 14 days in culture. 
 
7.2.3. Adhesion and proliferation of co-cultured cells on different surfaces 
Cell adhesion and proliferation was investigated by staining cells with rhodamine 
phalloidin (Cytoskeleton) and 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) 
(Invitrogen) nucleus stain by fluorescence microscope imaging after 7 days in culture. 
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Prior to staining non-adherent cells were removed by aspirating the cell rich medium 
from the surfaces followed by two gentle rinses with PBS. The surfaces were then transferred to 
a new 48-well plate and fixed with 3.7% formaldehyde 15 mins at room temperature. This was 
followed by incubating the surfaces in 1 % Triton-X 100 for 3 mins in order to permeabilize the 
cells. The surfaces were transferred to a new 48-well plate, then incubated in rhodamine-
phalloidin at a concentration of 5 μL/mL for 30 mins. DAPI was added at a concentration of 1 
μL/mL after 25 mins. All the surfaces were rinsed with PBS and imaged with a fluorescence 
microscope (Zeiss).  
 
7.2.4. Morphology of co-cultured cells on different surfaces 
The cell morphology was investigated using SEM imaging to visualize the cellular 
interaction with the surface nanoarchitecture. The non-adherent cells were removed by 
aspirating the cell rich media from the surfaces followed by two gentle rinses with PBS. The 
surfaces were then transferred to a clean petri dish where the cells were fixed and dehydrated. 
The cells were fixed by incubating the surfaces in a solution of primary fixative (3 % 
glutaraldehyde (Sigma), 0.1 M sodium cacodylate (Polysciences), and 0.1 M sucrose (Sigma)) 
for 45 min. They were then incubated in a solution of secondary fixative (primary fixative 
without gluteraldehyde) for 10 min. Subsequently, the surfaces were dehydrated by incubation 
in consecutive solutions of increasing ethanol concentrations (35 %, 50 %, 70 %, 95 %, and 100 
%) for 10 min each. Further dehydration of the cells was accomplished by incubating the 
surfaces in hexamethyldisilazane (HMDS, Sigma) for 10 min. They were then air dried and 
stored in a desiccator until further imaging by SEM. The surfaces were coated with a 10 nm 
layer of gold and imaged at 5-7 kV. 
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7.2.5. Differentiation of co-cultured cells on different surfaces 
Western blotting was performed to identify the expression of EC and SMC specific 
differentiation proteins, VE-cadherin and heavy chain myosin (MYH) respectively. Further, 
non-muscle specific myosin IIB (SMemb), a marker of undifferentiated SMCs was blotted for. 
Briefly, cells on surfaces after 7 and 14 days in culture were homogenized in RIPA lysis buffer 
(10.0 mM Tris pH 7.4, 100.0 mM NaCl, 5.0 mM EDTA, 5.0 mM EGTA, 1.0% Deoxycholate, 
0.1% SDS, 1.0% Triton X-100) containing protease inhibitor cocktail. The lysate protein 
content was determined by micro-BCA assay. The lysate was heated to 65 °C for 20 mins in 
sample buffer (62.5 mM Tris-HCl pH 6.8, 10.0 % glycerol, 5.0 % β-mercaptoethanol, 2.0% 
SDS, 0.025 % Bromophenol blue) in order to denature the proteins prior to gel loading. 
Approximately 20 µg of total extract protein was electrophoresed through 8 % Tris-SDS gels 
and transferred to PVDF membranes in 7.5% methanol. Blots were blocked for 1 hr at room 
temperature. Primary monoclonal antibodies for VE-cadherin, MYH or SMemb were diluted 
1:500 in 3% BSA in PBS-tween solution and incubated overnight at 4 °C. The blots were then 
washed three times with PBS-tween solution (5 mins per wash) before they were incubated with 
goat anti-mouse or donkey anti-rabbit horseradish peroxidase (HRP) conjugated secondary 
antibodies (Santa Cruz Biotechnology) at a dilution of 1:5000 for 1 hr at room temperature. The 
blots were then washed three times with PBS-tween solution (5 mins per wash) followed by 
protein detection using chemiluminescence (WestPico Chemiluminescent Substrate; Pierce).  
The blots were imaged using an Alpha Innotech Fluorchem gel documentation system, and 




7.3. Results and Discussion 
7.3.1. Characterization of Surfaces 
The surface architecture of the different surfaces before and after the collagen immobilization 
process was characterized using SEM. Results reveal that surface architecture remains consistent 
before and after collagen immobilization (Figure 7.1.).  
 
Figure 7.1. Representative SEM images of PCL and NW surfaces before and after collagen 
immobilization. 
10 µm 10 µm 
1 µm 1 µm 
PCL 
NW 
Unmodified + Collagen 
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7.3.2. Adhesion of co-cultured cells on different surfaces 
The adhesion of EC and SMC co-cultures on different surfaces was investigated after 7 
days in culture by using Rhodamine Phalloidin (Cytoskeleton) and 4′,6-diamidino-2-
phenylindole dihydrochloride (DAPI) (Invitrogen) nucleus stain, followed by imaging with a 
fluorescence microscope (Figure 7.2.). Results indicate that NW, cPCL and cNW surfaces are 
confluent with cells, unlike PCL surfaces. It is well known that both SMCs and ECs adhere 
better to either nanotopography or a bioactive surface, which PCL surfaces lack [14-17]. 
Further, it seems as if cells on all surfaces are aligning. High magnification images show 
cellular filopodia interactions with surrounding cells on all surfaces.  
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Figure 7.2. Representative fluorescence microscopy images of EC and SMC co-cultures stained 
with Rhodamine Phalloidin (red) and DAPI (blue) on PCL, NW, colPCL and colNW surfaces. 
Experiments were replicated on at least three different samples with at least three different cell 
populations (nmin = 9). 
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7.2.4. Morphology of co-cultured cells on different surfaces 
The cell morphology was investigated using SEM imaging to visualize the cellular 
interaction with the surface nanoarchitecture. The results indicate that NW, cPCL and cNW 
surfaces are confluent with cells (Figure 7.3.) Similar to fluorescence imaging results, high 
magnification images show cellular filopodia interactions with surrounding cells on all surfaces. 
Further, co-cultures on NW, cPCL and cNW surfaces appear more spindle-shaped (contractile-
appearing phenotype), with more evenly distributed cells.  
 
7.3.4. Differentiation of SMC and EC co-cultures on different surfaces 
 
The differentiation of ECs and SMCs in co-culture on surfaces was investigated by 
detecting VE-cadherin, MYH and SMemb expression through blotting techniques after 7 and 14 
days in culture. Both VE-cadherin and MYH are specific to a differentiated EC or SMC 
phenotype, respectively. VE-cadherin expression is important in cellular contacts, which will 
eventually regulate the permeability of the blood vessel therefore an increase in VE-cadherin 
expression is necessary for healthy vasculature.  
190 
Figure 7.3. Representative SEM images of SMC and EC co-cultures after 7 days of culture on 
different surfaces. Note: the surfaces were coated with a 10 nm layer of gold and imaged at 7 
keV. Experiments were replicated on at least three different samples with at least three different 
cell populations (nmin = 9). 
MYH expression is an end-state differentiation marker specific to SMCs while SMemb 
expression is an undifferentiated SMC marker. Down-regulation of SMC lineage markers has 
been shown to be associated with calcification [18]. Results indicate that normalized VE-
cadherin expression is statistically higher on PCL and NW surfaces after 7 days in culture
(Figure 7.4.b)). However, the normalized expression of VE-cadherin after 14 days in culture 
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decreases on both PCL and NW surfaces.  Normalized VE-cadherin expression on NW, cPCL 
and cNW surfaces increases significantly from 7 days in culture to 14 days in culture. Further 
normalized MYH expression significantly decreases on NW, cPCL and cNW surfaces (Figure 
7.4.c)), while no significant difference was seen in MYH expression on PCL surfaces from day 7 
to day 14. The combined results suggest that ECs are developing more cell-cell junctions via VE-
cadherin, and perhaps are still proliferating on NW, cPCL and cNW surfaces.  Once SMCs are in 
a differentiated state, their proliferation rates are significantly lower which would account for the 
decrease in MYH expression compared to total cell number on NW, cPCL and cNW surfaces. 
This is further verified by the significant decrease in SMemb expression on all surfaces (Figure 
7.4.d). Studies have shown that SMCs and ECs exhibit favorable interactions when co-cultured 
[19-21]. By incorporating nanotopography or a cell binding motif, more ECs and SMCs are able 
to attach, thus explaining the increased expression of differentiation proteins specific to ECs and 





Figure 7.4. Western blot analysis of the expression of (A) $-tubulin, (B) VE-cadherin, (C) MYH
and (D) SMemb on different surfaces after 7 and 14 days in culture. Experiments were replicated 
with western blots with at least three different cell populations (nmin = 9). (B) After 7 days in 
culture PCL and NW surfaces express significantly higher amounts of VE-cadherin compared to 
cPCL and cNW surfaces. After 14 days in culture VE-cadherin expression is significantly higher 
on NW and cNW surfaces compared to PCL and cPCL surfaces. (C) After 7 days in culture 
MYH expression is significantly higher on cNW surfaces compared to PCL, NW and cPCL 
surfaces, while PCL surfaces express significantly less MYH than NW, cPCL and cNW surfaces. 
After 14 days in culture, MYH expression significantly decreases on NW, cPCL and cNW 
surfaces. (D) After 7 days in culture SMemb expression is significantly higher on NW surfaces 
compared to PCL, cPCL and cNW surfaces. After 14 days in culture there is a significant 
decrease in SMemb expression on all surfaces, with no significant difference in expression 
between all surfaces. 
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7.3. Conclusions 
Cardiovascular tissue requires interactions between the endothelium with the underlying 
SMCs, which is vital for cardiovascular health and is considered to be important in the functions 
of blood vessels. In this study, we have investigated EC and SMC co-cultures on functionalized 
poly(ε-caprolactone) surfaces. In order to provide insights into the material surfaces’ feasibility 
for use as an interface in cardiovascular applications, EC and SMC co-culture adhesion, 
morphology and differentiation on different surfaces was investigated. Fluorescence imaging and 
SEM results reveal that NW, cPCL and cNW surfaces are confluent with cells. Further, ECs and 
SMCs on these surfaces seem to be more aligned and more spindle-shaped (contractile-appearing 
phenotype), with more evenly distributed cells. Western blotting results reveal that there is a 
significant increase in VE-cadherin expression after 14 days in culture on NW and cNW 
surfaces. MYH expression decreases on all surfaces from day 7 to day 14 in culture. The 
decrease in MYH expression can be attributed to the decrease in proliferation of differentiated 
SMCs. This is confirmed by the significant decrease in SMemb, an undifferentiated SMC marker 
from day 7 to day 14 in culture. However after 14 days in culture MYH expression is 
significantly higher on NW, cPCL and cNW surfaces compared to PCL surfaces.  These 
combined results indicate that NW and cNW surfaces may be good surfaces for use in 
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CONCLUSIONS AND FUTURE WORK 
 
8.1. Conclusions 
Cardiovascular disease is the leading killer of people worldwide. Synthetic implants are 
promising treatments, yet rejection of cardiovascular implants continues to be a problem, 
eliciting a need for understanding the mechanisms behind tissue-material interaction. An ideal 
cardiovascular implant surface must be capable of adhering cells and providing appropriate 
physiological responses while the surrounding tissue integrates with the scaffold.  However, 
tissue integration will not occur if the surface of the implant is not hemocompatible. A thorough 
understanding of the interaction of cardiovascular cells and whole blood and its components with 
the material surface is essential in order to have a successful application which promotes healing 
as well as native tissue integration and regeneration. In this study, the suitability of 
nanostructured polymeric surfaces as interfaces for cardiovascular applications was investigated 
by evaluating cellular response as well as hemocompatibility. 
The surface properties of implantable cardiovascular devices are critical for long-term 
success. This research has investigated the characteristics of similar sized features that are 
aligned differently; NWs are aligned perpendicular to the surface while NFs are aligned parallel 
to the surface. Further characteristics of collagen immobilized surfaces were also elucidated. 
These characteristics were evaluated using SEM, contact angle and XPS. Polycaprolactone NFs 
were fabricated with an electrospinning technique and a novel solvent-free template synthesis 
technique was used to fabricating controlled arrays of high aspect ratio, substrate-bound NWs. 
Surfaces were immobilized with collagen utilizing an aminolysis method. The resulting SEM 
images show the production of either horizontally oriented, uniform NFs or vertically oriented, 
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high aspect ratio and uniform NWs. Immobilizing collagen to the surfaces did not significantly 
alter the surface topography. Further, results identify a highly hydrophobic NF surface, while 
NW surfaces exhibit a more hydrophilic surface. The immobilization of collagen on the surfaces 
further decreases the contact angle. The simple fabrication, physiologically relevant architecture, 
low contact angle and large surface area identify nanowire surfaces as promising interfaces for 
implantable biomedical devices.  
 The hemocompatibility of nanostructured polycaprolactone surfaces (NW and NF) was 
investigated through the adsorption of key blood serum proteins (albumin, fibrinogen and 
immunoglobulin-g), platelet adhesion and activation and the clotting kinetics of whole human blood. 
Protein adsorption was evaluated using micro-BCA and XPS. The adhesion and activation of human 
platelets, isolated from whole human blood, were investigated using live-cell staining, MTT assay 
and SEM imaging. The clotting kinetics of whole human blood was evaluated by measuring the free 
hemoglobin concentration and further imaging by SEM to visualize the clot formation. The results 
indicate no significant differences in ALB adsorption on all surfaces. However, NW surfaces 
had higher total FIB and IgG adsorption compared to NF and PCL surfaces. In contrast, NW 
surfaces had lower surface FIB and IgG adsorption compared to NF and PCL surfaces. This can 
be explained based on the structure of FIB and IgG as well as the ability of the surfaces to 
allow protein infiltration. Platelet adhesion and viability studies show a large amount of 
adhesion and clustering of platelets on the NF surfaces as compared to PCL and NW surfaces. 
Platelet activation studies reveal that NW surfaces have the highest percentage of unactivated 
platelets, whereas NF surfaces have the highest percentage of fully activated platelets. Whole 
blood clotting results indicate that NW surfaces maintain an increased amount of free 
hemoglobin during the clotting process compared to PCL and NF surface, indicating less 
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clotting and slower rate of clotting on their surfaces. The results presented here indicate that 
the surface nanoarchitecture and how it is presented to the biological environment can 
modulate the hemocompatibility. Further, NW surfaces were identified as a more favorable 
template for blood-contacting surfaces. 
EC interaction with functionalized NW surfaces was investigated in terms of adhesion, 
proliferation, viability, morphology and differentiation. A thorough understanding of the 
interaction between ECs and the biomaterial surface is essential in order to promote healing and 
regeneration through integration with native tissue. One major obstacle to overcome is adhesion 
of the anchorage-dependent and slowly renewing ECs on material surfaces. The level of cell 
growth is also correlated to the characteristics of the material surface and its ability to mimic 
properties similar to extracellular matrix. Therefore, providing ECs with nanotopography and 
cell-binding motifs such as collagen may affect the cell adhesion, viability, morphology and 
differentiation. In this study, ECs exhibited increased adhesion and viability on NW, cPCL and 
cNW surfaces. ECs have a more elongated body and low shape factor on nanostructured 
surfaces (NW and cNW) compared to smooth surfaces (PCL and cPCL). The differentiation 
potential of collagen immobilized nanowire surfaces was also evaluated by immunostaining and 
western blotting for key endothelial cell markers, vWF and VE-cadherin. The expression of 
VE-cadherin is increased on nanostructured surfaces after 14 days in cuture, indicating more 
cell-cell contacts. The expression of vWF is statistically similar on all surfaces after 14 days in 
culture with no significant increase from 7 to 14 days in culture, indicating that increased 
perturbation of the endothelial layer on any surface is not occurring. The results presented here 
indicate that ECs adhesion and differentiation can be modulated by providing surfaces with 
nanotopography and cell binding motifs such as collagen.  
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SMC interaction with functionalized NW surfaces was investigated in terms of 
adhesion, proliferation, viability, morphology and differentiation. Inhibition of unnecessary 
vascular SMC proliferation and preservation of a differentiated state in SMCs are important 
aspects in the management and avoidance of vascular diseases. The level of cell functionality 
on biomaterial surfaces is also correlated to the characteristics of the surface and its ability to 
mimic properties similar to that of extracellular matrix. Therefore, providing SMCs with 
nanotopography and cell-binding motifs such as collagen may affect the cell adhesion, viability, 
morphology and differentiation. In this study, SMCs exhibited increased adhesion on NW, 
cPCL and cNW surfaces, however SMCs on nanostructured surfaces seemed to be more 
elongated than those on PCL surfaces. SEM results also revealed considerable amounts of 
filopodia interacting with surfaces and neighboring cells on NW, cPCL and cNW surfaces, but 
this interaction is lacking on PCL surfaces. The reduction of MTT was higher on flat surfaces 
(PCL and cPCL), indicating a higher rate of proliferation. This suggests that SMCs on 
nanostructured surfaces (NW and cNW) may be in a more differentiated state and slowly 
dividing.  This was confirmed by a significant increase in differentiation markers (CAL and 
MYH) on these surfaces after 7 days in culture without providing cells with differentiation 
cues. After giving the cells differentiation media, SMCs on all surfaces become spindle shaped. 
However the expression of endogenous proteins, CAL and MYH, specific to a contractile SMC 
phenotype is up-regulated on collagen immobilized surfaces (cPCL and cNW). These results 
suggest that nanotopography affects cell proliferation as well as cell elongation, while collagen 
immobilized surfaces greatly affect cell differentiation with proper differentiation cues. 
The thrombogenic effects of functionalized NW surfaces were investigated for their use 
as interfaces for blood-contacting implants. This study sheds light on the intricate relationship of 
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blood-biomaterial interactions.  The clotting cascade consists of many pathways that eventually 
converge to a common pathway and lead to the formation of a blood clot.  It is important to 
understand how components of the clotting cascade will interact with a biomaterial surface in 
order to be able to produce a truly biocompatible implant surface. The results presented her 
indicate a decrease in thrombogenic effects on NW surfaces compared to PCL, cPCL and cNW 
surfaces. Proteins found in plasma, such as thrombin and fibrinogen, molecules released from 
platelets and leukocytes and collagen are known to be potent platelet activators [16]. Findings 
from this study show that even surfaces coated with collagen did not produce fully activated 
platelets alone, but did produce more platelet aggregation, which is a very interesting finding. 
Although there were no significant differences in leukocyte adhesion, there was a decrease in 
platelet adhesion on NW surfaces. SEM images showed a decrease in platelet/leukocyte 
complexes on cNW surfaces and no apparent complexes were formed on NW surfaces compared 
to PCL and cPCL surfaces.  The increase in these complexes likely contributed to a higher 
expression of specific markers for platelet and leukocyte activation on PCL and cPCL surfaces. 
No significant differences were found in contact and complement activation. Further, thrombin 
anti-thrombin complexes were significantly reduced on NW surfaces. A significant increase in 
hemolysis and fibrinogen adsorption was identified on PCL surfaces likely caused by its 
hydrophobic surface. Further studies are now directed towards utilizing other coatings to further 
enhance the biocompatibility of NW surfaces. 
EC and SMC co-cultures on functionalized NW surfaces were investigated in terms of 
adhesion, morphology and differentiation. Cardiovascular tissue requires interactions between 
the endothelium with the underlying SMCs, which is vital for cardiovascular health and is 
considered to be important in the functions of blood vessels. In order to provide insights into the 
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material surfaces’ feasibility for use in cardiovascular applications, we looked at EC and SMC 
co-culture adhesion, morphology and differentiation on different surfaces. Fluorescence imaging 
and SEM results reveal that NW, cPCL and cNW surfaces are confluent with cells. Further, ECs 
and SMCs on these surfaces seem to be more aligned and more spindle-shaped (contractile-
appearing phenotype), with more evenly distributed cells. Western blotting results reveal that 
there is a significant increase in VE-cadherin expression and a significant decrease in MYH 
expression, both normalized to α-tubulin, on NW, cPCL and cNW surfaces. These results 
suggest that NW, cPCL and cNW surfaces may be good surfaces for use in cardiovascular 
applications and warrants further investigation.  
The results of this work suggest the improved biocompatibility of polycaprolactone NW 
surfaces. The findings indicate altered hemocompatibility and improved EC and SMC 
functionality. This research has promising implications with respect to the use of NW surfaces 
arrays as interfaces for cardiovascular implants.  
 
8.2. Future Work  
The simple solvent free nano-templating fabrication, physiologically appropriate 
topography, ease of biomolecular modification and appropriate interactions with both 
cardiovascular cells and whole blood and its components, identify polycaprolactone nanowire 
surfaces as promising interfaces for cardiovascular implants. There is a correlation between 
cellular response and nanotopography and this interaction can be optimized. Extruding the 
nanowires through membranes of varying pore sizes at different temperatures and periods of 
time can alter the diameters and lengths of the nanowires. Future studies will investigate the 
effects of varying nanowire characteristics on both cellular response and mechanical properties. 
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A more in depth study evaluating co-culture of ECs with SMCs, quantifying 
undifferentiated ECs and SMCs, is necessary to confirm results in Chapter 7. Further, studies 
aimed at elucidating the molecular mechanisms responsible for differentiation triggered by 
mechanical cues versus biochemical cues are necessary. In addition, a continuous flow set-up 
will be required in order to determine the success of these cardiovascular implant surfaces in a 
more physiologically relevant setting prior to in vivo studies. In vivo studies will investigate the 
long-term effect of polycaprolactone nanowire surfaces on healthy tissue development. This 
future research will provide answers to fundamental questions regarding the long-term 
functionality of polycaprolactone in highly representative scenarios. Future research will help 
direct the use of these interfaces for cardiovascular applications. 
 
 
 
